Tag Archives: Health

In the Garden of Indian Wisdom

Screen Shot 2018-05-19 at 11.53.38 PM

Ancient Ayurvedic medicine has found a new home at Acquaforte Thalasso & Spa. The same gentleness, the same intensity, the same wisdom. The result is our splendid Ayurvedic Park in the most secluded corner of our garden. Massages, yoga lessons, pilates. The body, relaxes, it listens, and it is happy.

Abhyanga

This is the “crowning” massage of Ayurvedic medicine. Hands glide over the body and envelop it in the warmth of oil perfumed with aromatic Indian essences, spices and medicinal plants. The effects are instant and profound: the blood and lymph circulation is reactivated, the spine relaxes, the muscles are toned and the body eliminates toxins, stress and fatigue.

Forteveda signature massage

First and foremost, posture and suppleness. This massage with Ayurvedic oil based on Indian herbs relaxes muscles and ligaments and ensures the posture of the body is correct, relaxed and harmonious.

Screen Shot 2018-05-19 at 11.54.04 PM

Shirodara and four hands treatment

Just say the word “shirodara” and you are whisked away to another dimension, with a massage that reaches into the very depths of your psyche. Opening the door to the mind and releasing all the tension is a trickle of warm oil that anoints the forehead. At the same time the therapists’ hands glide over the body and help you achieve inner peace in the gentlest way possible.

Hatha Flow & Vinyasa

From the very ancient discipline of yoga, a smooth series of asana to be performed by harmonizing the breath and movements, in order to control the hold and the configuration of every position.

Gentle Hatha

Ideal for all levels of physical ability, this gentle yoga combines a sequence of relaxing postures to practice meditation. What you gain is a new awareness helping you to balance body and mind perfectly.

Younga Yoga

From meditation, a new kind of suppleness

From the age-old wisdom of the East comes the answer to the problems we suffer from today: stress and anxiety, not to mention bad posture and stiffness. We are talking about yoga, a meditative practice that combines a spiritual quest with a vision that regenerates the body and breathing. In keeping with the holistic vision of its treatments and in the peace of its garden, Acquaforte Thalasso & Spa has set aside a special area for yoga, its schools and its most authoritative maestros.

In particular, Acquaforte Thalasso & Spa offers Yin Yoga that works on the “yin”, as against the dynamic “yang”, concentrating on the ligaments, tendons and joints. This discipline allows all the muscles to relax and strengthens the deepest connective tissue, improving flexibility and the whole body’s capacity for movement.

To learn more or to register for YOUR pH Miracle Retreat go to: http://www.phmiracleretreat.com and http://www.drrobertyoung.com

To learn more or to register for YOUR pH Miracle Retreat go to: http://phmiracleretreat.com/pH_miracle_retreat.html

The pH Miracle Health, Wellness and Fitness Retreats at Forte Village, Sardegna, Italy

 The pH Miracle Health, Wellness and Fitness Center at Forte Village, Sardegna, Italy – Rated by Forbes as one of the top 5 Resorts and Medical Spas in the World!
Watch the following video presentations to see the beauty and healing place of Forte Village Resort and Medical Spa in the blue zone of the World!

Taking YOUR reservations NOW – Email us at: http://www.phmiraclelife@gmail.com

Watch the video below as  YOU see what YOU will experience during your stay at one of the most incredible resorts and medical spas in the World!

1) A beautiful deluxe Bungalow within walking distance of the Spa, Pools, and beaches!

2) Alkalizing green juices daily

31747915_2051805275086382_5961724029176905728_o (2)

3) Alkaline breakfast, lunch, dinner and snacks

4) Seven alkalizing detoxing and energizing pools

 

5) Non-invasive blood testing (150 blood parameters tested), thermography and live and dried blood cell analysis

10431696_1430260873907495_2483446741826247915_n

6) Daily Yoga and mediation

7) Beautiful white sand beaches

8) Tennis (Clay, Grass and Hard Courts)

9) Salt water, aloe vera and magnesium pools for detoxification and pain relief

10) Bicycling

11) Bowling

12) Basketball

13) Hiking

14) Fitness Training Center

15) Daily Lymphatic Massage

16) Sports Center

17) Infrared Sauna

18) Turkish Bath

19) Steam Bath

20) Shopping

21) Night Life and Summer Concerts including the group Sting in July

22) Eighteen Restaruants

Check out the map of the Forte Village Resort!

Over 40 acres of beauty!

To learn more or for pricing contact us at: phmiraclelife@gmail.com or call 760-484-1075

12031526_871319916269947_7590942657912410753_o-1

Alkaline by Design

“The Human Body is a body of alkaline water, blood and mineral salts.” Robert O. Young CPT, MSc, DSc, PhD, Naturopathic Practitioner

524712_10151420549748317_1430510059_n.jpg

To learn more about your body and how to keep in hydrated and healthy read, The pH Miracle, The pH Miracle revised and updated, The pH Miracle for Weight Loss, The pH Miracle for Diabetes, The pH Miracle for Cancer, The pH Miracle for the Heart and Sick and Tired.

To order these books go to: http://www.phoreveryoung.com and https://www.amazon.com/Robert-O.-Young/e/B001ILKCSU/ref=sr_tc_2_0?qid=1525521720&sr=8-2-ent

 

 

Could Sodium or Potassium Bicarbonate save your life? Low levels of bicarbonate ‘are linked to a 24 % higher risk of early death!

Could Sodium or Potassium Bicarbonate save your life? Low levels of bicarbonate 'are linked to a 24 % higher risk of early death!

Robert Young PhD

Naturopathic Practitioner – The pH Miracle Ti Sana Detox Medical Spa

Could Sodium or Potassium Bicarbonate save your life? Low levels of bicarbonate ‘are linked to a 24 % higher risk of early death!

  • Compound in baking soda – bicarbonate – reduces early death, study found
  • Baking soda – or sodium bicarbonate – helps regulate pH levels  
  • People with low bicarbonate levels have 24% higher risk of early death
  • People should ingest fruit and green vegetables to get more bicarbonate!

Many of us think of baking soda as little more than a vital part of the recipe to making a cake or baking cookies.

But two new studies have found that the ingredients of sodium and/or potassium bicarbonate plays a far more important role in human health: It can help save lives.

Older people with low levels of sodium and/or potassiumbicarbonate – which is found in baking soda – have a 24 per cent higher risk of dying an early death!

The findings suggest increasing bicarbonate levels can prolong a person’s life.

Study author Dr Kalani Raphael, of the University of Utah, said: ‘What we found was that generally healthy older people with low levels of bicarbonate had a higher risk of death.’

Sodium bicarbonate, a main component of baking powder, reduces the risk of premature death, scientists revealed. Older people with low bicarbonate levels are 24 per cent more likely to die young, a study found

The kidneys and lungs work together by varying the levels of sodium and/or potassium bicarbonate – a base or alkaline compound – and carbon dioxide – an acid – in the blood, interstitial fluids and intracellular fluids.

Sodium and potassium bicarbonate helps keep the body’s pH in a healthy range (7.365), which allows the body cells that make up our organs to work properly.

Critically ill patients with severe acid-base abnormalities have very low levels of sodium and/or potassium bicarbonate and are very unlikely of surviving their illness, according to the study.

RELATED ARTICLES

  • Using Sodium and Potassium Bicarbonate in the Prevention and Treatment of ALL Sickness and Disease – Dr. Robert O. Young – www.phoreveryoung.com 

SHARE THIS ARTICLE

Yet, it has been unclear whether more subtle changes to the body’s acid-base status affect the longevity of relatively healthy older people.

A team of scientists investigated how measurements of pH, carbon dioxide and bicarbonate are associated with long-term survival in healthy older people.

They analyzed data from 2,287 participants in the health, aging and body composition study.

That data focused on well-functioning black and white adults between the ages of 70 and 79.

Data started being collected in 1997 – with collection efforts extending through February 2014.

Each of the participants were followed for an average of 10.3 years.

Scientists recommend people with low levels of sodium and/or potassium bicarbonate should increase their intake of foods that produce it in the body, including fruit and green vegetables.

Because of the study’s results, blood bicarbonate concentrations – which are already commonly measured – may allow clinicians to better identify people with a higher risk of premature death.

Those with low sodium and potassium bicarbonate levels may benefit from increasing their intake of foods that produce bicarbonate in the body – including fruit and vegetables, according to the scientists.

The study was published in the Clinical Journal of American Nephrology.  The study by Dr. Robert O. Young has been approved for publication in The International Journal of Complementary and Alternative Medicine.

Read more: http://www.phoreveryoung.wordpress.com

Using Alkalizing Herbs in the Prevention, Treatment and Reversal of Any Cancerous Condition

Dr. Robert O. Young MSc., DSc., Ph.D, ND

“The cure for cancer is found in its prevention NOT in its treatment”  Dr. Robert O. Young

Abstract

An anti-cancer lifestyle and diet is an important strategy you can use to reduce your risk for ANY cancerous condition. The American Cancer Society recommends, for example, that you eat at least five servings of fruit and vegetables daily and eat the right amount of (alkaline) food to stay at a healthy weight. In addition, researchers are finding that certain plant foods or herbs may be particularly useful in protecting and reversing many cancerous condition. The following article covers several of these medicinal herbs and their benefits in the prevention and treatment of brain cancer, lung cancer, breast cancer,  blood cancers,  prostate cancer, oral cancer, liver cancer thyroid cancer, kidney cancer, bowel cancer, stomach cancer, skin cancer and pancreatic cancer.

[Key words; cancer, chemotherapy, herbs, spices, natural cancer treatments, garlic, turmeric, ginger, cayenne, alkalizing, liver disease, oral cancer, prostate cancer, blood cancer, breast cancer, thyroid cancer, stomach cancer, skin cancer, pancreatic cancer, lung cancer, bowel cancer]

Introduction

Make room in your diet for the following foods and drinks to prevent cancer.  Why?  Because an ounce of prevention is worth more than a pound of cure.  The following are eleven herbs or spices that have been shown to be effective in the prevention, treatment and reversal of many cancerous conditions.

Garlic

[Figure 1: Cloves of garlic]

Several large studies have found that those who eat more garlic are less likely to develop various kinds of cancer, especially in digestive organs such as the esophagus, stomach, and colon. Ingredients in the pungent bulbs may keep cancer-causing substances in your body from working, or they may keep cancer cells from multiplying. I recommend a clove a day may be helpful.[1=22 ]

Cayenne Pepper

Most people know cayenne pepper for its spice. But it is actually an extraordinarily strong antioxidant and vaso-dialator. Studies have shown that by consuming cayenne pepper is highly alkaline and a powerful buffer of dietary and metabolic acids that cause cells to become cancerous. If you consume it regularly you can neutralize the acids that cause body cells to become cancerous.[23-29 ]

{Figure 2: Cyenne pepper]

Milk Thistle

Milk thistle is a crucial plant when it comes to liver health and cancer prevention. Milk thistle and the seeds from the plant can be used to eliminate acidic toxins that can bind to the liver, causing damage to the liver setting the stage for a cancerous condition. It protects the alkaline interstitial fluids that surround every body cell protecting them and indirectly preventing the formation of tumors, calcifications and/or cysts which make milk thistle a powerful antioxidant in the chelation of dietary and/or metabolic acids that cause cancer.[30-64 ]

[Figure 3: Milk Thistle]

Turmeric

 [Figure 4: Turmeric root and spice]

This orange-colored spice, a staple in Indian curries, contains an ingredient called curcumin (not the same as cumin) that might be useful in reducing cancer risk. According to the American Cancer Society, curcumin can inhibit some kinds of cancer cells in laboratory studies and slow the spread of cancer or shrink tumors in some animals. Turmeric is easy to find in grocery stores, and you can use it in a variety of recipes.[65-130 ]

Bloodroot

Bloodroot is actually used in a medicine for treating cancer named Black Salve. You can use bloodroot on its own, because it has been shown in tests to be effective in shrinking of tumors.[131-159]

[Figure 5: Bloodroot plant and flower]

Feverfew

Feverfew was used in a study at a university in New York. The study found that it was great at killing off leukemia cells, even better than the actual cancer medication.[160-191]

[Figure 6: Feverfew plant and flower]

Wheatgrass

Consuming one tiny glass of wheatgrass a day either orally or even-better rectally has shown to dramatically increase the health of cancer patients and non-cancer patients alike. It is particularly useful for people who are suffering from the side effects of chemotherapy. It will help purify the blood from dietary and/or metabolic acids, improve blood and lymph circulation, increase the oxygen levels in the microenvironments, and help the body repair and continue to reduce acids loads in the extracellular fluids, interstitial fluids and intracellular fluids to prevent and/or reverse and spoiling of the body cells.[192-204]

[Figure 7: Wheatgrass}

Ruscus Aculeatus

This herb is always known as Butchers Broom and it is great at fighting cancer due to its active ingredient, ruscogenins. The active ingredient has been proven to shrink tumors and increase the cancer fighting cells in the body.[205-221 ]

[Figure 8: Ruscus Aculeatus or Butchers Broom]

Sheep’s Sorrell

Sheep’s Sorrell can be used in people who are suffering the harmful effects of cancer medications. It helps the tissues rebuild and get back to the condition that they were in before the cancer and medication to use it was introduced. Some have suggested that it can be used to ward off cancer cells and keep them from growing.[222-224]

[Figure 9: Sheep’s Sorrel}

Astragalus

This herb is grown in China and has been proven to help with cancer on a couple of different levels. First it boosts your body’s immune system, which in turn helps it identify cancer cells. A study showed that cancer patients who took this herb survived twice as long.[225-250 ]

[Figure 10: Astragalus}

Ginger


[Figure 11: Ginger root]

A new study reveals ginger contains a pungent compound that could be up to 10,000 times more effective than conventional chemotherapy in targeting the cancer stem cells at the root of cancer malignancy. [251]

[Figure 12: Research Shows The Efficacy of Ginger Root as a non-toxic form of chemotherapy]

The authors of the study further affirm these points:

“Cancer stem cells pose serious obstacle to cancer therapy as they can be responsible for poor prognosis and tumour relapse. To add into the misery, very few chemotherapeutic compounds show promise to kill these cells. Several researchers have shown that cancer stem cells are resistant to paclitaxel, doxorubicin, 5-fluorouracil, and platinum drugs [8, 16]. CSCs are thus an almost unreachable population in tumours for chemotherapy. Therefore any compound, that shows promise towards cancer stem cells, is a highly desirable step towards cancer treatment and should be followed up for further development.”

The researchers identified a variety of ways by which 6-shagoal targets breast cancer:

  • It reduces the expression of CD44/CD24 cancer stem cell surface markers in breast cancer spheroids (3-dimensional cultures of cells modeling stem cell like cancer)
  • It significantly affects the cell cycle, resulting in increased cancer cell death
  • It induces programmed cell death primarily through the induction of autophagy, with apoptosis a secondary inducer
  • It inhibits breast cancer spheroid formation by altering Notch signaling pathway through γ-secretase inhibition.
  • It exhibits cytotoxicity (cell killing properties) against monolayer (1-dimensional cancer model) and spheroid cells (3-dimensional cancer model)

It was in evaluating the last mode of 6-shagoal’s chemotherapeutic activity and comparing it to the activity of the conventional chemotherapeutic agent taxol that the researchers discovered an astounding difference. Whereas taxol exhibited clear cytotoxicity in the one-dimensional (flat) monolayer experimental model, it had virtually no effect on the spheroid model, which is a more “real world” model reflecting the 3-dimensionality of tumors and their stem cell subpopulations. Amazingly, this held true even when the concentration of taxol was increased by four orders of magnitude:

 “In contrast [to 6-shagoal], taxol, even though was highly active in monolayer cells, did not show activity against the spheroids even at 10000 fold higher concentration compared to 6-shogoal.”

This is a highly significant finding, as it affirms a common theme in cancer research that acknowledges the primarily role of cancer stem cells: namely, while conventional techniques like surgery, radiation, and chemotherapy are effective at reducing a tumor’s size, sometimes to the point where it is “debulked,” burned,” or “poisoned” out of the body even below the threshold of re-detection, the appearance of “winning the battle” often comes at a steep price, as ultimately the cancer stem cell population regrows the tumors, now with increased vengeance and metastastic invasiveness, resulting in the cancer “winning the war.”

The monolayer model, which does not account for the complex immunity of actual cancer stem-cell based tumors against chemoagents like taxol, represents the old preclinical model of testing cancer treatments. The spheroid model, on the other hand, clearly shows that even 10,000 times higher concentrations of taxol are not capable of beating this ginger component at selectively targeting the root cause of the tumor malignancy.

In their concluding remarks, the authors point out a hugely important distinction between natural anti-cancer agents and conventional ones that have only been introduced in the past half century or so, namely, “Dietary compounds are welcome options for human diseases due to their time-tested acceptability by human bodies.”  

Unlike modern synthetically produced and patented chemicals, ginger, curcumin, garlic, and hundreds of other compounds naturally found in the human diet, have been “time-tested” as acceptable to the human body in the largest and longest running “clinical trials” known: the tens of thousands of years of direct human experience, spanning thousands of different cultures from around the world, that constitute human prehistory. These experientially-based “trials” are validated not by RCTs, or a peer-reviewed publication process, but by the fact that we all made it through this incalculably vast span of time to be alive here today. Consider also that if our ancestors made the wrong dietary choice by simply mistaking an edible berry for a poisonous one, the consequences could be deadly. This places even greater emphasis on how the “time testing” of dietary compounds was not an academic but a life-death affair, and by implication, how the information contained within various cultural traditions as “recipes” passed down from generation to generation are “epigenetic inheritance systems” no less important to our health and optimal gene expression as the DNA in our own bodies.

Ultimately, this new study adds to a growing body of research indicating that cancer stem cell targeting approaches using natural substances present in the human diet for thousands of years are far superior than chemotherapy and radiation, both of which actually increase the relative populations of cancer stem cells versus non-tumorigenic ones.[251]

Cannabis

[Figure 11: Cannabis plant with buds]

Cannabis has been making a lot of noise lately. Multiple states across the United States and countries around the world have successfully legalized medical Marijuana, and the Uruguay parliament recently voted to create the world’s first legal marijuana market.[252-256] This is good news as the health benefits of Cannabis are vast, with multiple medical and scientific studies that confirm them. On the other hand, arguments against the use of marijuana is usually published in Psychiatric journals, which show no scientific evidence that Cannabis is harmful to human health. All psychological evaluations from the intake of cannabis are largely based on assumptions, suggestions and observations (257). When we look at the actual science behind Cannabis, the health benefits can be overwhelming. So what does one who opposes the use of cannabis base their belief on? Nothing, not scientific evidence anyways. The negative stigmatism attached to marijuana is due to it’s supposed psychotropic effects, yet again, there is no scientific evidence to show that marijuana has any psychotropic effects. Nonetheless, cannabis has recently been the focus of medical research and considered as a potential therapeutic treatment and cure for cancer.Cannabis is a great example of how the human mind is programmed and conditioned to believe something. Growing up, we are told drugs are bad, which is true, however not all substances that have been labelled as “drugs” by the government are harmful. Multiple substances are labelled as a “drug” in order to protect corporate interests. One example is the automobile and energy industry, a car made from hemp is stronger than steel, and can be fuelled from hemp alone. Henry Ford demonstrated this many years ago. Hemp actually has over 50,000 uses![258]Let’s take a look at the science behind Cannabis and Cancer. Although Cannabis has been proven to be effective for a large range of ailments, this article will focus mainly on it’s effectiveness in the treatment of cancer. Cannabinoids may very well be one of the best disease and cancer fighting treatments out there. Cannabinoids refer to any of a group of related compounds that include cannabinol and the active constituents of cannabis. They activate cannabinoid receptors in the body. The body itself produces compounds called endocannabinoids and they play a role in many processes within the body that help to create a healthy environment. Cannabinoids also play a role in immune system generation and re-generation. The body regenerates best when it’s saturated with Phyto-Cannabinoids. Cannabinoids can also be found in Cannabis. It is important to note that the cannabinoids are plentiful in both hemp and cannabis. One of the main differentiations between hemp and cannabis is simply that hemp only contains 0.3% THC while cannabis is 0.4% THC or higher. (Technically they are both strains of Cannabis Sativa.)  Cannabinoids have been proven to reduce cancer cells as they have a great impact on the rebuilding of the immune system. While not every strain of cannabis has the same effect, more and more patients are seeing success in cancer reduction in a short period of time by using cannabis.While taking a look at these studies, keep in mind that cannabis can be much more effective for medicinal purposes when we eat it rather than smoking it. Below are 20 medical studies that prove cannabis can be an effective treatment and possible cure for cancer.[ [259-288] Please keep in mind that this is a very short list of studies that support the use of medicinal marijuana. Please feel free to further your research, hopefully this is a good starting point.

Brain Cancer

A study published in the British Journal of Cancerconducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid, this study determined that Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth. They were responsible for the first clinical study aimed at assessing cannabinoid antitumoral action. Cannabinoid delivery was safe and was achieved with zero psychoactive effects. THC was found to decrease tumour cells in two out of the nine patients.[289]A study published in The Journal of Neuroscience examined the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. They conducted a magnetic resonance imaging study that looked at THC (the main active compound in marijuana) and found that it reduced neuronal injury in rats. The results of this study provide evidence that the cannabinoid system can serve to protect the brain against neurodegeneration.[290]A study published in The Journal of Pharmacology And Experimental Therapeutics already acknowledged the fact that cannabinoids have been shown to possess antitumor properties. This study examined the effect of cannabidiol (CBD, non psychoactive cannabinoid compound) on human glioma cell lines. The addition of cannabidiol led to a dramatic drop in the viability of glioma cells. Glioma is the word used to describe brain tumour.  The study concluded that cannabidiol was able to produce a significant antitumor activity.[291]A study published in the journal Molecular Cancer Therapeutics outlines how brain tumours are highly resistant to current anticancer treatments, which makes it crucial to find new therapeutic strategies aimed at improving the poor prognosis of patients suffering from this disease. This study also demonstrated the reversal of tumour activity in Glioblastoma multiforme.[292]

Breast Cancer

A study published in the US National Library of Medicine, conducted by the California Pacific Medical Centre determined that cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.[293]A study published in The Journal of Pharmacology and Experimental Therapeutics determined that THC as well as cannabidiol dramatically reduced breast cancer cell growth. They confirmed the potency and effectiveness of these compounds.[294]A study published in the Journal Molecular Cancer showed that THC reduced tumour growth and tumour numbers. They determined that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis and impair tumour angiogenesis (all good things). This study provides strong evidence for the use of cannabinoid based therapies for the management of breast cancer.[295]A study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) determined that cannabinoids inhibit human breast cancer cell proliferation.[296]

Lung Cancer

A study published in the journal Oncogeneby Harvard Medical Schools Experimental Medicine Department determined that THC inhibits epithelial growth factor induced lung cancer cell migration and more. They go on to state that THC should be explored as novel therapeutic molecules in controlling the growth and metastasis of certain lung cancers.[297 ]A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology, from the Department of General Surgery in Germany determined that cannabinoids inhibit cancer cell invasion. Effects were confirmed in primary tumour cells from a lung cancer patient.  Overall, data indicated that cannabinoids decrease cancer cell invasiveness.[298 ]A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated the role of cannabinoid receptors in lung cancer cells. They determined its effectiveness and suggested that it should be used for treatment against lung cancer cells.[299 ]

Prostate Cancer

A study published in the US National Library of Medicine illustrates a decrease in prostatic cancer cells by acting through cannabinoid receptors.[300]A study published in the US National Library of Medicine outlined multiple studies proving the effectiveness of cannabis on prostate cancer.[301]Another study published by the US National Library of Medicine determined that clinical testing of CBD against prostate carcinoma is a must. That cannabinoid receptor activation induces prostate carcinoma cell apoptosis. They determined that cannabidiol significantly inhibited cell viability.[302]

Blood Cancer

A study published in the journal Molecular Pharmacology recently showed that cannabinoids induce growth inhibition and apoptosis in matle cell lymphoma. The study was supported by grants from the Swedish Cancer Society, The Swedish Research Council and the Cancer Society in Stockholm.[303]A study published in the International Journal of Cancer also determined and illustrated that cannabinoids exert antiproliferative and proapoptotic effects in various types of cancer and in mantle cell lymphoma.[304]A study published in the US National Library of Medicine conducted by the Department of Pharmacology and Toxicology by Virginia Commonwealth University determined that cannabinoids induce apoptosis in leukemia cells.[305]

Oral Cancer

A study published by the US National Library of Medicine results show cannabinoids are potent inhibitors of cellular respiration and are toxic to highly malignant oral Tumours. [306]

Liver Cancer

A study published by the US National Library of Medicine determined that that THC reduces the viability of human HCC cell lines (Human hepatocellular liver carcinoma cell line) and reduced the growth.[307]

Pancreatic Cancer

A study published in The American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results showed that cannabinoid administration induced apoptosis. They also reduced the growth of tumour cells, and inhibited the spreading of pancreatic tumour cells.[308]

Conclusion

According to a 2004 report by Morgan, Ward, and Barton: “The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. … survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA.”Jun 16, 2014[309]

Medical oncologists are a long way from using medicinal herbs as an alternative or primary treatment for cancer.  The research is significant and shows that the medicinal herbs discussed in this article are extraordinary plants and have shown excellent results in the prevention, treatment and reversal of many cancerous conditions.

References:

  1. Milner JA. Garlic: Its anticarcinogenic and antitumorigenic properties. Nutrition Reviews1996; 54:S82–S86.
  2. Ross SA, Finley JW, Milner JA. Allyl sulfur compounds from garlic modulate aberrant crypt formation. Journal of Nutrition 2006; 136(3 Suppl):852S–854S.
  3. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. Intake of garlic and its bioactive components. Journal of Nutrition 2001; 131(3s):955S–962S.
  4. Amagase H. Clarifying the real bioactive constituents of garlic. Journal of Nutrition 2006; 136(3 Suppl):716S–725S.
  5. Fleischauer AT, Arab L. Garlic and cancer: A critical review of the epidemiologic literature. Journal of Nutrition 2001; 131(3s):1032S–1040S.
  6. Gonzalez CA, Pera G, Agudo A, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). International Journal of Cancer 2006; 118(10): 2559–2566.
  7. Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, Potter JD. Vegetables, fruit, and colon cancer in the Iowa Women’s Health Study. American Journal of Epidemiology 1994; 139(1):1–15.
  8. Gao CM, Takezaki T, Ding JH, Li MS, Tajima K. Protective effect of allium vegetables against both esophageal and stomach cancer: A simultaneous case-referent study of a high-epidemic area in Jiangsu Province, China. Japanese Journal of Cancer Research1999; 90(6):614–621.
  9. Setiawan VW, Yu GP, Lu QY, et al. Allium vegetables and stomach cancer risk in China. Asian Pacific Journal of Cancer Prevention 2005; 6(3):387–395.
  10. Hsing AW, Chokkalingam AP, Gao YT, et al. Allium vegetables and risk of prostate cancer: A population-based study. Journal of the National Cancer Institute 2002; 94(21):1648–1651.
  11. Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiology Biomarkers & Prevention 2005; 14(9):2093–2097.
  12. Challier B, Perarnau JM, Viel JF. Garlic, onion and cereal fibre as protective factors for breast cancer: A French case-control study. European Journal of Epidemiology 1998; 14(8):737–747.
  13. Li H, Li HQ, Wang Y, et al. An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chinese Medical Journal (English) 2004; 117(8):1155–1160.
  14. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. Journal of the National Cancer Institute 2006; 98(14):974–983.
  15. Tanaka S, Haruma K, Kunihiro M, et al. Effects of aged garlic extract (AGE) on colorectal adenomas: A double-blinded study. Hiroshima Journal of Medical Sciences 2004; 53(3–4):39–45.
  16. Tilli CM, Stavast-Kooy AJ, Vuerstaek JD, et al. The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis. Archives of Dermatological Research 2003; 295(3):117–123.
  17. Ruddock PS, Liao M, Foster BC, et al. Garlic natural health products exhibit variable constituent levels and antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. Phytotherapy Research 2005; 19(4):327–334.
  18. Shenoy NR, Choughuley AS. Inhibitory effect of diet related sulphydryl compounds on the formation of carcinogenic nitrosamines. Cancer Letters 1992; 65(3):227–232.
  19. Milner JA. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Advances in Experimental Medicine and Biology2001; 492:69–81.
  20. L’vova GN, Zasukhina GD. Modification of repair DNA synthesis in mutagen-treated human fibroblasts during adaptive response and the antimutagenic effect of garlic extract. Genetika 2002; 38(3):306–309.
  21. Boon H, Wong J. Botanical medicine and cancer: A review of the safety and efficacy. Expert Opinion on Pharmacotherapy 2004; 5(12):2485–2501.
  22. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clinical Infectious Diseases 2002; 34(2):234–238.Athanasiou A., et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun 2007 Mar 2; 354(1): 50-55.
  23. Athanasiou A., et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death.  2007 Mar 2; 354(1): 50-55.
  24. Christensen, Jon. (December 12, 2005). Retrieved from The New York Times. Scientist at work: John Reed; running hot in pursuit of cancer treatment).
  25. Hu, Janny.  (October 12, 2004). Lakers Suite Tomjanovich to a T. San Francisco Chronicle on The Web. Retrieved from http://www.sfgate.com/sports/article/Lakers-suit-coach-Tomjanovich-to-a-T-2641695.php.
  26. Mori, Akio, et al. (March 15, 2006). Capsaicin, A Component of Red Peppers, Inhibits The Growth of Androgen-Independent, p53 Mutant Prostate Cancer Cells. American Association of Cancer Research.
  27. Samid, Dvorit. (1997). Compositions and methods for treating and preventing pathologies including cancer. The USA Dept. of HHS; pg. 56.
  28. Sanchez AM et al. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis 2007; 12(11): 2013-24.
  29. Thoennissen NH, O’Kelly J, Lu D, et al. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene. 2010, Jan 14;29(2):285-96.  
  30. PDR® for Herbal Medicines™. 2nd ed. Montvale, NJ: Medical Economics, 2000.
  31. Lee DY, Liu Y: Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle). J Nat Prod 66 (9): 1171-4, 2003. [PUBMED Abstract]
  32. Napolitano JG, Lankin DC, Graf TN, et al.: HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin case. J Org Chem 78 (7): 2827-39, 2013. [PUBMED Abstract]
  33. Hruby K, Csomos G, Fuhrmann M, et al.: Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Hum Toxicol 2 (2): 183-95, 1983. [PUBMED Abstract]
  34. Wagner H, Hörhammer L, Münster R: [On the chemistry of silymarin (silybin), the active principle of the fruits from Silybum marianum (L.) Gaertn. (Carduus marianus L.)] Arzneimittelforschung 18 (6): 688-96, 1968. [PUBMED Abstract]
  35. Campos R, Garrido A, Guerra R, et al.: Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver. Planta Med 55 (5): 417-9, 1989. [PUBMED Abstract]
  36. Farghali H, Kameniková L, Hynie S, et al.: Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 41 (2): 231-7, 2000. [PUBMED Abstract]
  37. Lettéron P, Labbe G, Degott C, et al.: Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol 39 (12): 2027-34, 1990. [PUBMED Abstract]
  38. Zhao J, Agarwal R: Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. Carcinogenesis 20 (11): 2101-8, 1999. [PUBMED Abstract]
  39. Valenzuela A, Guerra R, Videla LA: Antioxidant properties of the flavonoids silybin and (+)-cyanidanol-3: comparison with butylated hydroxyanisole and butylated hydroxytoluene. Planta Med (6): 438-40, 1986. [PUBMED Abstract]
  40. Valenzuela A, Guerra R, Garrido A: Silybin dihemisuccinate protects rat erythrocytes against phenylhydrazine-induced lipid peroxidation and hemolysis. Planta Med 53 (5): 402-5, 1987. [PUBMED Abstract]
  41. Valenzuela A, Aspillaga M, Vial S, et al.: Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Med 55 (5): 420-2, 1989. [PUBMED Abstract]
  42. Mira ML, Azevedo MS, Manso C: The neutralization of hydroxyl radical by silibin, sorbinil and bendazac. Free Radic Res Commun 4 (2): 125-9, 1987. [PUBMED Abstract]
  43. Mira L, Silva M, Manso CF: Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem Pharmacol 48 (4): 753-9, 1994. [PUBMED Abstract]
  44. Koch HP, Löffler E: Influence of silymarin and some flavonoids on lipid peroxidation in human platelets. Methods Find Exp Clin Pharmacol 7 (1): 13-8, 1985. [PUBMED Abstract]
  45. Garrido A, Arancibia C, Campos R, et al.: Acetaminophen does not induce oxidative stress in isolated rat hepatocytes: its probable antioxidant effect is potentiated by the flavonoid silybin. Pharmacol Toxicol 69 (1): 9-12, 1991. [PUBMED Abstract]
  46. Bosisio E, Benelli C, Pirola O: Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol Res 25 (2): 147-54, 1992 Feb-Mar. [PUBMED Abstract]
  47. Altorjay I, Dalmi L, Sári B, et al.: The effect of silibinin (Legalon) on the the free radical scavenger mechanisms of human erythrocytes in vitro. Acta Physiol Hung 80 (1-4): 375-80, 1992. [PUBMED Abstract]
  48. El-Shitany NA, Hegazy S, El-Desoky K: Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. Phytomedicine 17 (2): 116-25, 2010. [PUBMED Abstract]
  49. Scambia G, De Vincenzo R, Ranelletti FO, et al.: Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin. Eur J Cancer 32A (5): 877-82, 1996. [PUBMED Abstract]
  50. Bhatia N, Zhao J, Wolf DM, et al.: Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. Cancer Lett 147 (1-2): 77-84, 1999. [PUBMED Abstract]
  51. Zi X, Agarwal R: Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci U S A 96 (13): 7490-5, 1999. [PUBMED Abstract]
  52. Duthie SJ, Johnson W, Dobson VL: The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells. Mutat Res 390 (1-2): 141-51, 1997. [PUBMED Abstract]
  53. Vailati A, Aristia L, Sozzé E, et al.: Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis. Fitoterapia 64 (3), 219-28, 1993.
  54. Salmi HA, Sarna S: Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. Scand J Gastroenterol 17 (4): 517-21, 1982. [PUBMED Abstract]
  55. Parés A, Planas R, Torres M, et al.: Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 28 (4): 615-21, 1998. [PUBMED Abstract]
  56. Moscarella S, Giusti A, Marra F, et al.: Therapeutic and antilipoperoxidant effects of silybin-phosphatidylcholine complex in chronic liver disease: preliminary results. Current Therapeutic Research 53 (1): 98-102.
  57. Marena C, Lampertico M: Preliminary clinical development of silipide: a new complex of silybin in toxic liver disorders. Planta Med 57 (Suppl 2): A124-5, 1991.
  58. Marcelli R, Bizzoni P, Conte D, et al.: Randomized controlled study of the efficacy and tolerability of a short course of IdB 1016 in the treatment of chronic persistent hepatitis. European Bulletin of Drug Research 1 (3): 131-5, 1992.
  59. Flisiak R, Prokopowicz D: Effect of misoprostol on the course of viral hepatitis B. Hepatogastroenterology 44 (17): 1419-25, 1997 Sep-Oct. [PUBMED Abstract]
  60. Ferenci P: [Therapy of chronic hepatitis C] Wien Med Wochenschr 150 (23-24): 481-5, 2000. [PUBMED Abstract]
  61. Buzzelli G, Moscarella S, Giusti A, et al.: Therapeutic effects of a new silybin complex in chronic active hepatitis (CAH). [Abstract] Hellenic Journal of Gastroenterology 5 (Suppl): A-151, 38, 1992.
  62. Albrecht M, Frerick H, Kuhn U, et al.: Therapy of toxic liver pathologies with Legalon®. Z Klin Med 47: 87-92, 1992.
  63. Rambaldi A, Jacobs BP, Gluud C: Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev (4): CD003620, 2007. [PUBMED Abstract]
  64. Yang Z, Zhuang L, Lu Y, et al.: Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials. Biomed Res Int 2014: 941085, 2014. [PUBMED Abstract]
  65. Bachmeier BE, Mirisola V, Romeo F, et al. Reference profile correlation reveals estrogen-like trancriptional activity of Curcumin. Cell Physiol Biochem. 2010;26(3):471-482.
  66. Cemil B, Topuz K, Demircan MN, et al. Curcumin improves early functional results after experimental spinal cord injury. Acta Neurochir (Wien). Sep 2010;152(9):1583-1590; discussion 1590.
  67. Seehofer D, Schirmeier A, Bengmark S, et al. Inhibitory effect of curcumin on early liver regeneration following partial hepatectomy in rats. J Surg Res. Aug 2009;155(2):195-200.
  68. Yun JM, Jialal I, Devaraj S. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. May 2011;22(5):450-458.
  69. Jantan I, Bukhari SN, Lajis NH, et al. Effects of diarylpentanoid analogues of curcumin on chemiluminescence and chemotactic activities of phagocytes. J Pharm Pharmacol.Mar 2012;64(3):404-412.
  70. Chang KW, Hung PS, Lin IY, et al. Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression. Int J Cancer. Jul 1 2010;127(1):9-20.
  71. Siwak DR, Shishodia S, Aggarwal BB, et al. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.Cancer. Aug 15 2005;104(4):879-890.
  72. Uddin S, Hussain AR, Manogaran PS, et al. Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene. Oct 27 2005;24(47):7022-7030.
  73. Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. Apr 15 2007;67(8):3853-3861.
  74. Selvendiran K, Ahmed S, Dayton A, et al. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Cancer Biol Ther. Nov 1 2011;12(9):837-845.
  75. Sreekanth CN, Bava SV, Sreekumar E, et al. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene. Jul 14 2011;30(28):3139-3152.
  76. Qiao Q, Jiang Y, Li G. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-kappaB pathway: an in-vitro study of lymphoma. Anticancer Drugs.Jan 23 2012
  77. Kunnumakkara AB, Diagaradjane P, Guha S, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res. Apr 1 2008;14(7):2128-2136.
  78. Ng TP, Chiam PC, Lee T, et al. Curry consumption and cognitive function in the elderly.Am J Epidemiol. Nov 1 2006;164(9):898-906.
  79. Baum L, Lam CW, Cheung SK, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. Feb 2008;28(1):110-113.
  80. Bundy R, Walker AF, Middleton RW, et al. Turmeric extract may improve irritable bowel syndrome symptomatology in otherwise healthy adults: a pilot study. J Altern Complement Med. Dec 2004;10(6):1015-1018.
  81. Hanai H, Iida T, Takeuchi K, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterol Hepatol. Dec 2006;4(12):1502-1506.
  82. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014 Mar 20;9:451-8.
  83. Pungcharoenkul K, Thongnopnua P. Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects. Phytother Res. Nov 2011;25(11):1721-1726
  84. Baum L, Cheung SK, Mok VC, et al. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol Res. Dec 2007;56(6):509-514.
  85. expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. Mar 2011;29(3):208-213.
  86. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. Jul 15 2008;14(14):4491-4499.
  87. Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.Cancer Biol Ther. Jan 2010;9(1):8-14.
  88. Kanai M, Yoshimura K, Asada M, et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol. Jul 2011;68(1):157-164.
  89. Epelbaum R, Schaffer M, Vizel B, et al. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer. 2010;62(8):1137-1141.
  90. Zhang W, Lim LY. Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro. Drug Metab Dispos. Jul 2008;36(7):1283-1290.
  91. Chen Y, Liu WH, Chen BL, et al. Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers. Ann Pharmacother.Jun 2010;44(6):1038-1045.
  92. Somasundaram S, Edmund NA, Moore DT, et al. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. Jul 1 2002;62(13):3868-3875.
  93. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons; 1996.
  94. Morsy MA, Abdalla AM, Mahmoud AM, et al. Protective effects of curcumin, alpha-lipoic acid, and N-acetylcysteine against carbon tetrachloride-induced liver fibrosis in rats. J Physiol Biochem. Oct 11 2011.
  95. Bulku E, Stohs SJ, Cicero L, et al. Curcumin exposure modulates multiple pro-apoptotic and anti-apoptotic signaling pathways to antagonize acetaminophen-induced toxicity. Curr Neurovasc Res. Feb 1 2012;9(1):58-71.
  96. Alexandrow MG, Song LJ, Altiok S, et al. Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer. Eur J Cancer Prev. Dec 7 2011.
  97. Lin SS, Lai KC, Hsu SC, et al. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett. Nov 28 2009;285(2):127-133.
  98. Chen QY, Lu GH, Wu YQ, et al. Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep. May 2010;23(5):1285-1292.
  99. Wu SH, Hang LW, Yang JS, et al. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res. Jun 2010;30(6):2125-2133.
  100. de H, Tokiwa S, Sakamaki K, et al. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate. Jul 1 2010;70(10):1127-1133.
  101. Wong TF, Takeda T, Li B, et al. Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition. Gynecol Oncol. Jul 2011;122(1):141-148
  102. Bartik L, Whitfield GK, Kaczmarska M, et al. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.J Nutr Biochem. Dec 2010;21(12):1153-1161.
  103. Watson JL, Hill R, Lee PW, et al. Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner. Exp Mol Pathol. Jun 2008;84(3):230-233.
  104. Yang KY, Lin LC, Tseng TY, et al. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. Jun 15 2007;853(1-2):183-189.
  105. Garcea G, Berry DP, Jones DJ, et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. Jan 2005;14(1):120-125.
  106. Bishnoi M, Chopra K, Rongzhu L, et al. Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence. Neurotox Res. Oct 2011;20(3):215-225.
  107. Tsai YM, Chien CF, Lin LC, et al. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm. Sep 15 2011;416(1):331-338.
  108. Orr WS, Denbo JW, Saab KR, et al. Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition. Surgery. Jan 26 2012.
  109. Asai A, Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci. Oct 27 2000;67(23):2785-2793.
  110. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 1980;16(3):259-265.
  111. Hou XL, Takahashi K, Tanaka K, et al. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int J Pharm. Jun 24 2008;358(1-2):224-229.
  112. Zhang W, Tan TM, Lim LY. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos. Jan 2007;35(1):110-115.
  113. Appiah-Opong R, Commandeur JN, van Vugt-Lussenburg B, et al. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products.Toxicology. Jun 3 2007;235(1-2):83-91.
  114. Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. May 2008;87(5):1262-1267.
  115. Ulbricht CE, Basch, EM. Natual Standard Herb & Supplement Reference: Evidence-Based Clinical Reviews St. Louis, MO: Elsevier Mosby; 2005.
  116. Lamb SR, Wilkinson SM. Contact allergy to tetrahydrocurcumin. Contact Dermatitis.Apr 2003;48(4):227.
  117. Liddle M, Hull C, Liu C, et al. Contact urticaria from curcumin. Dermatitis. Dec 2006;17(4):196-197.
  118. Prakash P, Misra A, Surin WR, et al. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res. Feb 2011;127(2):111-118.
  119. Jantan I, Raweh SM, Sirat HM, et al. Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation. Phytomedicine. Apr 2008;15(4):306-309.
  120. Pavithra BH, Prakash N, Jayakumar K. Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits. J Vet Sci. Dec 2009;10(4):293-297.
  121. Kudva AK, Manoj, MN, Swamy, BM, et al. Complexation of amphotericin B and curcumin with serum albumins: solubility and effect on erythrocyte membrane damage. J Exp Pharmacol. 2011;2011(3):1-6.
  122. Hudson SA, Ecroyd H, Kee TW, et al. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. Oct 2009;276(20):5960-5972.
  123. Egashira K, Sasaki H, Higuchi S, Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. Drug Metab Pharmacokinet. 2012 Apr 25;27(2):242-7.
  124. Choi HA, Kim MR, Park KA, Hong J. Interaction of over-the-counter drugs with curcumin: influence on stability and bioactivities in intestinal cells. J Agric Food Chem.2012 Oct 24;60(42):10578-84.
  125. Akazawa N, Choi Y, Miyaki A, et al. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr Res. 2012 Oct;32(10):795-9.
  126. Sanmukhani J, Satodia V, Trivedi J, et al. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. 2014 Apr;28(4):579-85.
  127. Niu M, Wu S, Mao L, Yang Y. CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice. Traffic. 2013 Oct;14(10):1042-52.
  128. Palatty PL, Azmidah A, Rao S, et al. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study. Br J Radiol. 2014 Jun;87(1038):20130490.
  129. Thomas R, Williams M, Sharma H, Chaudry A, Bellamy P. A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the U.K. NCRN Pomi-T study. Prostate Cancer Prostatic Dis. 2014 Jun;17(2):180-6.
  130. Daveluy A, Geniaux H, Thibaud L, et al. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa). Therapie. Nov-Dec 2014;69(6):519-520.
  131. Doctor Accused of Aiding Man Who Disfigured Cancer Patients. The Washinton Post.http://www.washingtonpost.com/wp-dyn/content/article/2005/08/13/AR2005081301016.html. Accessed August 17, 2015.
  132. Adhami VM, Aziz MH, Mukhtar H, et al. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin Cancer Res 2003;9(8):3176-82.
  133. Adhami VM, Aziz MH, Reagan-Shaw SR, et al. Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther 2004;3(8):933-40.
  134. Basini G, Santini SE, Bussolati S, et al. The plant alkaloid sanguinarine is a potential inhibitor of follicular angiogenesis. J Reprod Dev 2007;53(3):573-9.
  135. Basini G, Santini SE, Bussolati S, et al. Sanguinarine inhibits VEGF-induced Akt phosphorylation. Ann N Y Acad Sci 2007;1095:371-6.
  136. Chaturvedi MM, Kumar A, Darnay BG, et al. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem 1997;272(48):30129-34.
  137. Ding Z, Tang SC, Weerasinghe P, et al. The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochem Pharmacol 2002;63(8):1415-21.
  138. Dzink JL, Socransky SS. Comparative in vitro activity of sanguinarine against oral microbial isolates. Antimicrob Agents Chemother 1985;27(4):663-5.
  139. Eun JP, Koh GY. Suppression of angiogenesis by the plant alkaloid, sanguinarine.Biochem Biophys Res Commun 2004;317(2):618-24.
  140. Eversole LR, Eversole GM, Kopcik J. Sanguinaria-associated oral leukoplakia: comparison with other benign and dysplastic leukoplakic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89(4):455-64.
  141. Fetrow C. Professional’s handbook of complementary and alternative medicines 2nd ed. 2001, Springhouse, PA: Springhouse Corp.
  142. Hakim SA, Sanguinarine and hypothalamic glaucoma. J All India Ophthalmol Soc. 1962 Dec;10:83-102.
  143. Jeng JH, Wu HL, Lin BR, et al. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Atherosclerosis2007;191(2):250-8.
  144. Mascarenhas AK, Allen CM, Loudon J. The association between Viadent use and oral leukoplakia. Epidemiology. 2001;12(6):741-3.
  145. McDaniel S, Goldman GD. Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer. Arch Dermatol 2002;138(12):1593-6.
  146. Munro IC, Delzell ES, Nestmann ER, et al. Viadent usage and oral leukoplakia: a spurious association. Regul Toxicol Pharmacol 1999;30(3):182-96.
  147. Nandi R, Maiti M. Binding of sanguinarine to deoxyribonucleic acids of differing base composition. Biochem Pharmacol 1985;34(3):321-4.
  148. Scheiner-Bobis G. Sanguinarine induces K+ outflow from yeast cells expressing mammalian sodium pumps. Naunyn Schmiedebergs Arch Pharmacol 2001;363(2):203-8.
  149. Seifen E, Adams RJ, Riemer RK. Sanguinarine: a positive inotropic alkaloid which inhibits cardiac Na+,K+-ATPase. Eur J Pharmacol 1979;60(4):373-7.
  150. Suchomelova J, Bochorakova H, Paulova H, et al. HPLC quantification of seven quaternary benzo[c]phenanthridine alkaloids in six species of the family Papaveraceae. J Pharm Biomed Anal 2007;44(1):283-7.
  151. Wolff J, Knipling L. Antimicrotubule properties of benzophenanthridine alkaloids.Biochemistry 1993;32(48):13334-9.
  152. Mazzio EA, Soliman KF. In vitro screening for the tumoricidal properties of international medicinal herbs. Phytother Res. 2009 Mar;23(3):385-98.
  153. Han MH, Yoo YH, Choi YH. Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. Chemotherapy.2008;54(3):157-65.
  154. Saltzberg F, Barron G, Fenske N. Deforming self-treatment with herbal “black salve”.Dermatol Surg. 2009 Jul;35(7):1152-4.
  155. Sun M, Liu C, Nadiminty N, et al. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate. 2011 May 2. doi: 10.1002/pros.21409.
  156. Cienki JJ, Zaret L. An Internet misadventure: bloodroot salve toxicity. J Altern Complement Med. 2010 Oct;16(10):1125-7.
  157. Lee JS, Jung WK, Jeong MH, Yoon TR, Kim HK. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway. Int J Toxicol. 2012 Jan-Feb;31(1):70-7.
  158. Eastman KL, McFarland LV, Raugi GJ. Buyer beware: a black salve caution. J Am Acad Dermatol. 2011 Nov;65(5):e154-5.
  159. Schlichte MJ, Downing CP, Ramirez-Fort M, Gordon R, Tyring S. Bloodroot associated eschar. Dermatol Online J. 2014 Jul 15;20(7). pii: 13030/qt05r0r2wr
  160. Martin K, Sur R, Liebel F, et al. Parthenolide-depleted feverfew (Tanacetum parthenium) protects skin from UV irradiation and external aggression. Arch Dermatol Res. Feb 2008;300(2):69-80. doi: 10.1007/s00403-007-0818-x
  161. Izumi E, Morello LG, Ueda-Nakamura T, et al. Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Exp Parasitol. Mar 2008;118(3):324-330. doi: 10.1016/j.exppara.2007.08.015
  162. Mohsenzadeh F, Chehregani A, Amiri H. Chemical composition, antibacterial activity and cytotoxicity of essential oils of Tanacetum parthenium in different developmental stages. Pharm Biol. Sep 2011;49(9):920-926. doi: 10.3109/13880209.2011.556650
  163. Mathema VB, Koh YS, Thakuri BC, et al. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities. Inflammation. Apr 2012;35(2):560-565. doi: 10.1007/s10753-011-9346-0
  164. Wu C, Chen F, Wang X, et al. Identification of antioxidant phenolic compounds in feverfew (Tanacetum parthenium) by HPLC-ESI-MS/MS and NMR. Phytochem Anal.Sep-Oct 2007;18(5):401-410. doi: 10.1002/pca.995
  165. Diener HC, Pfaffenrath V, Schnitker J, et al. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention – A randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia. Nov 2005;25(11):1031-1041. doi: 10.1111/j.1468-2982.2005.00950.x
  166. Cady RK, Goldstein J, Nett R, et al. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic M) in the treatment of migraine. Headache.Jul-Aug 2011;51(7):1078-1086. doi: 10.1111/j.1526-4610.2011.01910.x
  167. Ferro EC, Biagini AP, da Silva IE, et al. The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study.Acupunct Med. Dec 2012;30(4):252-257. doi: 10.1136/acupmed-2012-010195
  168. Pattrick M, Heptinstall S, Doherty M. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Ann Rheum Dis. Jul 1989;48(7):547-549.
  169. Kim SL, Lee ST, Trang KT, et al. Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer. Int J Mol Med. May 2014;33(5):1261-1267. doi: 10.3892/ijmm.2014.1669
  170. Al-Fatlawi AA, Al-Fatlawi AA, Irshad M, et al. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines. Pharm Biol. Jan 2015;53(1):104-109. doi: 10.3109/13880209.2014.911919
  171. Lu C, Wang W, Jia Y, et al. Inhibition of AMPK/autophagy potentiates parthenolide-induced apoptosis in human breast cancer cells. J Cell Biochem. Aug 2014;115(8):1458-1466. doi: 10.1002/jcb.24808
  172. Yip-Schneider MT, Nakshatri H, Sweeney CJ, et al. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. Mol Cancer Ther. Apr 2005;4(4):587-594. doi: 10.1158/1535-7163.MCT-04-0215
  173. Zhang S, Ong CN, Shen HM. Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis. Cancer Lett. Aug 10 2004;211(2):175-188. doi: 10.1016/j.canlet.2004.03.033
  174. Parada-Turska J, Paduch R, Majdan M, et al. Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells.Pharmacol Rep. Mar-Apr 2007;59(2):233-237.
  175. Lesiak K, Koprowska K, Zalesna I, et al. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro. Melanoma Res. Feb 2010;20(1):21-34. doi: 10.1097/CMR.0b013e328333bbe4
  176. Carlisi D, D’Anneo A, Angileri L, et al. Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. J Cell Physiol. Jun 2011;226(6):1632-1641. doi: 10.1002/jcp.22494
  177. Curry EA, 3rd, Murry DJ, Yoder C, et al. Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. Invest New Drugs. Aug 2004;22(3):299-305. doi: 10.1023/B:DRUG.0000026256.38560.be
  178. Guzman ML, Rossi RM, Neelakantan S, et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood.Dec 15 2007;110(13):4427-4435. doi: 10.1182/blood-2007-05-090621
  179. Pareek A, Suthar M, Rathore GS, et al. Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn Rev. Jan 2011;5(9):103-110. doi: 10.4103/0973-7847.79105
  180. Reuter U, Chiarugi A, Bolay H, et al. Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol. Apr 2002;51(4):507-516.
  181. Sahler J, Bernard JJ, Spinelli SL, et al. The feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-kappaB inhibition. Thromb Res. May 2011;127(5):426-434. doi: 10.1016/j.thromres.2010.12.013
  182. Groenewegen WA, Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro. J Pharm Pharmacol. Aug 1990;42(8):553-557.
  183. Heptinstall S, White A, Williamson L, et al. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet. May 11 1985;1(8437):1071-1074.
  184. Johnson ES, Kadam NP, Hylands DM, et al. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed). Aug 31 1985;291(6495):569-573.
  185. Williams CA, Hoult JR, Harborne JB, et al. A biologically active lipophilic flavonol from Tanacetum parthenium. Phytochemistry. Jan 1995;38(1):267-270.
  186. Anderson KN, Bejcek BE. Parthenolide induces apoptosis in glioblastomas without affecting NF-kappaB. J Pharmacol Sci. Feb 2008;106(2):318-320.
  187. Paulsen E, Christensen LP, Andersen KE. Compositae dermatitis from airborne parthenolide. Br J Dermatol. Mar 2007;156(3):510-515. doi: 10.1111/j.1365-2133.2006.07674.x
  188. Killoran CE, Crawford GH, Pedvis-Leftick A. Two cases of compositae dermatitis exacerbated by moisturizer containing feverfew. Dermatitis. Dec 2007;18(4):225-229.
  189. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom. 2004;18(19):2273-2281. doi: 10.1002/rcm.1621
  190. Collins SC, Dufresne RG, Jr. Dietary supplements in the setting of mohs surgery.Dermatol Surg. Jun 2002;28(6):447-452.
  191. Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet. Jul 23 1988;2(8604):189-192.
  192. Kothari S, Jain AK, Mehta SC, et al. Hypolipidemic effect of fresh Triticum aestivum (wheat) grass juice in hypercholesterolemic rats. Acta Pol Pharm. Mar-Apr 2011;68(2):291-294.
  193. Sethi J, Yadav M, Dahiya K, et al. Antioxidant effect of Triticum aestivium (wheat grass) in high-fat diet-induced oxidative stress in rabbits. Methods Find Exp Clin Pharmacol. May 2010;32(4):233-235.
  194. Shyam R, Singh SN, Vats P, et al. Wheat grass supplementation decreases oxidative stress in healthy subjects: a comparative study with spirulina. J Altern Complement Med. Oct 2007;13(8):789-791.
  195. Ben-Arye E, Goldin E, Wengrower D, et al. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol. Apr 2002;37(4):444-449.
  196. Ng SC, Lam YT, Tsoi KK, et al. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. Oct 2013;38(8):854-863.
  197. Marawaha RK, Bansal D, Kaur S, et al. Wheat grass juice reduces transfusion requirement in patients with thalassemia major: a pilot study. Indian Pediatr. Jul 2004;41(7):716-720.
  198. Choudhary DR, Naithani R, Panigrahi I, et al. Effect of wheat grass therapy on transfusion requirement in beta-thalassemia major. Indian J Pediatr. Apr 2009;76(4):375-376.
  199. Singh K, Pannu MS, Singh P, et al. Effect of wheat grass tablets on the frequency of blood transfusions in Thalassemia Major. Indian J Pediatr. Jan 2010;77(1):90-91.
  200. Bar-Sela G, Tsalic M, Fried G, et al. Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study. Nutr Cancer.2007;58(1):43-48.
  201. Das A, Raychaudhuri U, Chakraborty R. Effect of freeze drying and oven drying on antioxidant properties of fresh wheatgrass. Int J Food Sci Nutr. Sep 2012;63(6):718-721.
  202. Shukla V, Vashistha M, Singh SN. Evaluation of antioxidant profile and activity of amalaki (Emblica officinalis), spirulina and wheat grass. Indian J Clin Biochem. Jan 2009;24(1):70-75.
  203. Gerritsen ME, Carley WW, Ranges GE, et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol. Aug 1995;147(2):278-292.
  204. Mukhopadhyay S, et al. The role of iron chelation activity of wheat grass juice in patients with myelodysplastic syndrome. Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No 15S (May 20 Supplement), 2009: 7012
  205. Blumenthal M, et al. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council; 1998
  206. Foster S, et al. Tyler’s Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies, 3rd ed. New York: Haworth Herbal Press; 1993.
  207. Blumenthal M, et al. Herbal Medicine Expanded Commission E Monographs, 1st ed. Austin: American Botanical Council; 2000.
  208. Vanscheidt W, et al. Efficacy and safety of a Butcher’s broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiencyArzneimittelforschung 2002;52:243-50.
  209. Cluzan RV, et al. Treatment of secondary lymphedema of the upper limb with CYCLO 3 FORT. Lymphology 1996 Mar;29(1):29-35.
  210. Cappelli R, Nicora M, DiPerri T. Use of extract of Ruscus aculeatus in venous disease in the lower limbs. Drugs Exp Clin Res 1988;14(4):277-83.
  211. Thomas-Anterion C, et al. Unexplained chronic diarrhea, apropos of 4 new cases under Cyclo 3 fort and review of the literature. Rev Med Interne 1993 Apr;14(4):215-7. Review.
  212. Boyle P, Diehm C, Robertson C. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. Int Angiol. 2003 Sep;22(3):250-62.
  213. Guex JJ, Enriquez Vega DM, Avril L, Boussetta S, Taïeb C. Assessment of quality of life in Mexican patients suffering from chronic venous disorder – impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment – ’QUALITY Study’.Phlebology. 2009 Aug;24(4):157-65.
  214. Huang YL, Kou JP, Ma L, et al. Possible mechanism of the anti-inflammatory activity of ruscogenin: role of intercellular adhesion molecule-1 and nuclear factor-kappaB. J Pharmacol Sci. 2008 Oct;108(2):198-205.
  215. Guex JJ, Avril L, Enrici E, et al. Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study). Int Angiol. 2010 Dec;29(6):525-32.
  216. De Marino S, Festa C, Zollo F, Iorizzi M. Novel steroidal components from the underground parts of Ruscus aculeatus L. Molecules. 2012 Nov 26;17(12):14002-14.
  217. Longo L, Vasapollo G. Determination of anthocyanins in Ruscus aculeatus L. berries. J Agric Food Chem. 2005 Jan 26;53(2):475-9.
  218. Barbič M, Schmidt TJ, Jürgenliemk G. Novel phenyl-1-benzoxepinols from butcher’s broom (Rusci rhizoma). Chem Biodivers. 2012 Jun;9(6):1077-83.
  219. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch Pharm (Weinheim). 1995 Oct;328(10):720-4.
  220. Barbič M, Willer EA, Rothenhöfer M, Heilmann J, Fürst R, Jürgenliemk G. Spirostanol saponins and esculin from Rusci rhizoma reduce the thrombin-induced hyperpermeability of endothelial cells. Phytochemistry. 2013 Jun;90:106-13.
  221. Sadarmin PP, Timperley J. An unusual case of Butcher’s Broom precipitating diabetic ketoacidosis. J Emerg Med. 2013 Sep;45(3):e63-5.
  222. Tamayo C, et al. The chemistry and biological activity of herbs used in Flor-essence herbal tonic and Essiac. Phytotherapy Res 2000;14:1-14.
  223. Fetrow CW, et al. Professional’s Handbook of Complementary and Alternative Medicines. Philadelphia: Springhouse; 1999.
  224. Newall CA, et al. Herbal medicines: a guide for health-care professionals. Pharmaceutical Press. London. 1996.
  225. Chu DT, Wong WL, Mavligit GM. Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivoJ Clin Lab Immunol 1988;25:125-9.
  226. Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004540.
  227. McCulloch M, See C, Shu XJ, et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trialsJ Clin Oncol. 2006 Jan 20;24(3):419-30.
  228. Cui R, He J, Wang B, et al. Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol. 2003 Jan;51(1):75-80.
  229. Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus.Cancer Lett. Jul 8 2007;252(1):43-54.
  230. Yu L, Lu Y, Li J, Wang H. Identification of a gene associated with astragalus and angelica’s renal protective effects by silver staining mRNA differential display. Chin Med J (Engl) 2002;115:923-7.
  231. Ahmed MS, Hou SH, Battaglia MC, et al. Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus. Am J Kidney Dis. Dec 2007;50(6):1028-1032.
  232. Ai P, Yong G, Dingkun G, et al. Aqueous extract of Astragali Radix induces human natriuresis through enhancement of renal response to atrial natriuretic peptide. J Ethnopharmacol. Mar 28 2008;116(3):413-421.
  233. Shen HH, Wang K, Li W, et al. Astragalus Membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition.J Ethnopharmacol. Mar 5 2008;116(2):363-369.
  234. Chen KT, Su CH, Hsin LH, et al. Reducing fatigue of athletes following oral administration of huangqi jianzhong tang. Acta Pharmacol Sin. 2002 Aug;23(8):757-61.
  235. Shi R, He L, Hu Y, et al. The regulatory action of radix astragali on M-cholinergic receptor of the brain of senile ratsJ Tradit Chin Med 2001;21:232-5.
  236. Tang W, et al. Chinese Drugs of Plant Origin. Berlin: Springer-Verlag; 1992.
  237. Qun L, Luo Q, Zhang ZY, et al. Effects of astragalus on IL-2/IL-2R system in patients with maintained hemodialysis. Clin Nephrol. 1999 Nov;52(5):333-4.
  238. Chu DT, Lepe-Zuniga J, Wong WL, et al. Fractionated extract of Astragalus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2J Clin Lab Immunol 1988;26:183-7.
  239. Upton R. Astragalus root: analytical, quality control and therapeutic monograph. American Herbal Pharmacopoeia. 1999;1:1-25.
  240. Wu P, Dugoua JJ, Eyawo O, Mills EJ. Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. J Exp Clin Cancer Res.2009 Aug 12;28(1):112.
  241. Lu MC, Yao CH, Wang SH, et al. Effect of Astragalus membranaceus in rats on peripheral nerve regeneration: in vitro and in vivo studies. J Trauma. 2010 Feb;68(2):434-40.
  242. Wojcikowski K, Wohlmuth H, Johnson DW, Gobe G. Effect of Astragalus membranaceus and Angelica sinensis combined with Enalapril in rats with obstructive uropathy. Phytother Res. 2010 Jun;24(6):875-84.
  243. Auyeung KK, Woo PK, Law PC, Ko JK. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J Ethnopharmacol. 2011 Aug 12.
  244. Guo L, Bai SP, Zhao L, Wang XH. Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival. Med Oncol. 2011 Sep 18.
  245. Zhang WJ, Wojta J, Binder BR. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression. J Vasc Res. 1997 Jul-Aug;34(4):273-80.
  246. Chen HW, Lin IH, Chen YJ,  et al. A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study.Clin Invest Med. 2012 Feb 1;35(1):E1-11.
  247. Zhang CZ, Wang SX, Zhang Y, Chen JP, Liang XM. In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms. J Ethnopharmacol. 2005 Apr 26;98(3):295-300.
  248. Fu J, Wang Z, Huang L, et al. Review of the Botanical Characteristics, Phytochemistry, and Pharmacology of Astragalus membranaceus (Huangqi). Phytother Res. 2014 Sep;28(9):1275-83.
  249. Xu X, Li F, Zhang X, et al. In vitro synergistic antioxidant activity and identification of antioxidant components from Astragalus membranaceus and Paeonia lactiflora. PLoS One. 2014 May 9;9(5):e96780. doi: 10.1371/journal.pone.0096780. eCollection 2014.
  250. Ji L, Chen X, Zhong X, et al. Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy. BMC Complement Altern Med.2014 Jun 18;14:195. doi: 10.1186/1472-6882-14-
  251. Anasuya Ray, Smreti Vasudevan, Suparna Sengupta, 6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death.  Published: September 10, 2015. DOI: 10.1371/journal.pone.0137614
  252. 195.http://www.theguardian.com/world/2013/aug/03/uruguay-cannabis-
  253. lawhttp://www.presstv.ir/detail/2013/08/01/316632/uruguay-passes-bill-on-
  254. marijuana/http://www.ctvnews.ca/business/uruguay-taking-steps-to-become-first-nation-with-legal-marijuana-industry-1.1393211
  255. http://news.yahoo.com/uruguays-house-oks-legal-marijuana-market-plan-024441970.html(1)
  256. http://edrv.endojournals.org/content/27/1/73.fullhttp://rstb.royalsocietypublishing.org/content/367/1607/3326.abstract?sid=20cf2c23-e4fd-49e3-9398-ec8be2e00226.
  257. A.  JOHNS, Psychiatric effects of cannabis. SUBSTANCE MISUSE PAPERS, 
  258. IBID.
  259. Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68(7):515-521.
  260. Ahmedzai S, Carlyle DL, Calder IT, Moran F. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Br J Cancer. 1983;48(5):657-663.
  261. American College of Physicians. Supporting research into the therapeutic role of marijuana. (Position paper, 2008.) Accessed at http://www.acponline.org/advocacy/where_we_stand/other_issues/medmarijuana.pdf on March 4, 2015.
  262. Bhattacharyya S, Crippa JA, Allen P, et al. Induction of psychosis by {delta}9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry. 2012;69(1):27-36.
  263. Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage. 1995;10(2):89-97.
  264. Beal JE, Olson R, Lefkowitz L, et al. Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage. 1997;14(1):7-14.
  265. Cannabis-In-Cachexia-Study-Group, Strasser F, Luftner D, Possinger K, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Onc. 2006;24:3394-3400.
  266. Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009;34(3):672-680.
  267. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.
  268. Haney M, Rabkin J, Gunderson E, Foltin RW. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology. (Berl). 2005;181:170-178.
  269. Haney M, Gunderson EW, Rabkin J, et al. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood,and sleep. J Acquir Immune Defic Syndr. 2007;45(5):545-554.
  270. Herman TS, Einhorn LH, Jones SE, et al. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med. 1979;300(23):1295-1297.
  271. Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol. 2002;20(2):567-573.
  272. Johnson JR, Burnell-Nugent M, Lossignol D, et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167-179.
  273. Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage. 2013;46(2):207-218.
  274. Karst M, Salim K, Burstein S, et al. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA. 2003;290:1757-1762.
  275. Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(17):1556-1563.
  276. Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2014 Dec 10.
  277. Meiri E, Jhangiani H, Vredenburgh JJ, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin. 2007;23(3):533-543.
  278. Musty RE, Rossi R. Effects of Smoked Cannabis and Oral Δ9-Tetrahydrocannabinol on Nausea and Emesis After Cancer Chemotherapy: A Review of State Clinical Trials. Journal of Cannabis Therapeutics. 2001; 1(1): 29-56.
  279. National Cancer Institute. Cannabis and Cannabinoids (PDQ®) Health Professional Version, updated 12/17/14. Accessed at http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional on March 4, 2015.
  280. Portenoy RK, Ganae-Motan ED, Allende S, et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438-449.
  281. Radwan MM, Elsohly MA, Slade D, et al. Biologically active cannabinoids from high-potency Cannabis sativa. J Nat Prod. 2009;72(5):906-911.
  282. Rog DJ, Nurmikko TJ, Young CA. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther. 2007;29(9):2068-2079.
  283. Ross SA, ElSohly MA, Sultana GN, et al. Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L. Phytochem Anal. 2005;16(1):45-48.
  284. Smith PF. New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids. Ther Clin Risk Manag. 2010;6:59-63.
  285. Tramér MR, Carroll D, Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001;323:16-21.
  286. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010;182(14):E694-701.
  287. Wilsey B, Marcotte T, Deutsch R, et al. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013;14(2):136-148.
  288. Woolridge E, Barton S, Samuel J, et al. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage. 2005;29:358-367.
  289. M Guzmán, M J Duarte, C Blázquez, J Ravina, M C Rosa, I Galve-Roperh, C Sánchez, G Velasco and L González-Feria, A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme, British Journal of Cancer (2006) 95, 197–203. doi:10.1038/sj.bjc.6603236 www.bjcancer.com Published online 27 June 2006.
  290.  M. van der SteltW. B. VeldhuisP. R. BärG. A. VeldinkJ. F. G. Vliegenthart, and K. Nicolay, Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity.  The Journal of Neuroscience, 1 September 2001, 21(17): 6475-6479.
  291. Paola MassiAngelo VaccaniStefania CerutiArianna ColomboMaria P. Abbracchio and Daniela ParolaroAntitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines.  JPET March 2004 vol. 308 no. 3 838-845.
  292. Sofía TorresMar Lorente1Fátima Rodríguez-Fornés1Sonia Hernández-Tiedra1María Salazar1,2, A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma.  doi: 10.1158/1535-7163.MCT-10-0688Mol Cancer Therapy, January 2011 10; 90.
  293. McAllister SDMurase RChristian RTLau DZielinski AJAllison JAlmanza CPakdel ALee JLimbad CLiu YDebs RJMoore DHDesprez PY,  Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.  Breast Cancer Res Treat. 2011 Aug;129(1):37-47. doi: 10.1007/s10549-010-1177-4. Epub 2010 Sep 22.
  294. Alessia Ligresti, Aniello Schiano Moriello, Katarzyna Starowicz, Isabel Matias, Simona Pisanti, Luciano De Petrocellis, Chiara Laezza, Giuseppe Portella, Maurizio Bifulco and Vincenzo Di Marzo,  Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.   Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, CNR Pozzuoli, Italy (AL, ASM, KS, IM, VDM); Istituto di Cibernetica, CNR Pozzuoli, Italy (ASM, LDP); Dipartimento di Biologia e Patologia Cellulare e Molecolare “L.Califano”, Università di Napoli “Federico II”(SP, CL, GP, MB) and Dipartimento di Scienze Farmaceutiche, Università degli Studi di Salerno, Fisciano, Italy (SP, MB).
  295. María M CaffarelClara AndradasEmilia MiraEduardo Pérez-GómezCamilla CeruttiGema Moreno-BuenoJuana M FloresIsabel García-RealJosé PalaciosSantos MañesManuel Guzmán and Cristina Sánchez, Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition, Molecular Cancer20109:196, 22 July 2010.
  296. LUCIANO DE PETROCELLIS, DOMINIQUE MELCK, ANTONELLA PALMISANO§, TIZIANA BISOGNO, CHIARA LAEZZA, MAURIZIO BIFULCO, AND VINCENZO DI MARZO, The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.  Proc. Natl. Acad. Sci. USA, Vol. 95, pp. 8375–8380, July 1998 Pharmacology.
  297. A Preet, R K Ganju, J E Groopman,  Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.  Oncogene (2008) 27, 339–346; doi:10.1038/sj.onc.1210641; published online 9 July 2007
  298. Ramer R1, Bublitz KFreimuth NMerkord JRohde HHaustein MBorchert PSchmuhl ELinnebacher MHinz B.,  Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J. 2012 Apr;26(4):1535-48. doi: 10.1096/fj.11-198184. Epub 2011 Dec 23.
  299.  Preet AQamri ZNasser MWPrasad AShilo KZou XGroopman JEGanju RK, Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res (Phila). 2011 Jan;4(1):65-75. doi: 10.1158/1940-6207.CAPR-10-0181. Epub 2010 Nov 19.
  300. Mimeault MPommery NWattez NBailly CHénichart JP.  Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.  Prostate. 2003 Jun 15;56(1):1-12.
  301. Juan A. Ramos and  Fernando J. Bianco, The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications.  Indian J Urol. 2012 Jan-Mar; 28(1): 9–14.
  302. De Petrocellis LLigresti ASchiano Moriello AIappelli MVerde RStott CGCristino LOrlando PDi Marzo V, Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Br J Pharmacol. 2013 Jan;168(1):79-102. doi: 10.1111/j.1476-5381.2012.02027.
  303.  Kristin GustafssonBirger ChristenssonBirgitta Sander and Jenny FlygareCannabinoid Receptor-Mediated Apoptosis Induced by R(+)-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma.  Molecular PharmacologyNovember 2006 vol. 70 no. 5 1612-1620.
  304. Kristin Gustafsson, Xiao Wang1, Denise Severa1, Maeve Eriksson1, Eva Kimby2, Mats Merup2, Birger Christensson1, Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation. International Journal of Cancer, Volume 123,  Issue 5pages 1025–10331 September 2008.
  305. Jia WHegde VLSingh NPSisco DGrant SNagarkatti MNagarkatti PS, Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol Cancer Res. 2006 Aug;4(8):549-62.
  306.  Whyte DAAl-Hammadi SBalhaj GBrown OMPenefsky HSSouid AK.  Cannabinoids inhibit cellular respiration of human oral cancer cells. Pharmacology. 2010;85(6):328-35. doi: 10.1159/000312686. Epub 2010 Jun 2.
  307. Vara DSalazar MOlea-Herrero NGuzmán MVelasco GDíaz-Laviada, Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ. 2011 Jul;18(7):1099-111. doi: 10.1038/cdd.2011.32. Epub 2011, April 8.
  308. A. Carracedo, M. Gironella, M. Lorente, S. Garcia, M. Guzam, F. Velasco, J. Lovanna, Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress–Related Genes. Cancer Research, The American Association of Cancer Research, 2006, May 5.
  309. Morgan G1, Ward RBarton M.The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.  Clin Oncol (R Coll Radiol). 2004 Dec;16(8):549-60.

– See more at: www.phoreveryoung.com

The Cure for Cancer? That’s an easy question to answer! The Cure for Cancer is Found in its Prevention NOT in its Treatment! – Dr. Robert O. Young

Do you know what rotten apples, grapefruit or bananas look like? If you do then you know what cancer cells look like. Cancer cells are nothing more that healthy cells that are spoiling because of a compromised environment! Look at the picture below and you will see colorized cancerous body cells rotting in their toxic acidic environment.

What compromises the internal environment of a human body that causes body cells to begin spoiling and rotting? The answer is simple! The body’s build-up of acidic metabolic and dietary waste that has not been properly eliminated through the four channels of elimination – urination, defecation, respiration and perspiration!

Cancer is not a noun but an adjective that describes what is happening to body cells in an acidic environment due to an acidic lifestyle and diet. www.phoreveryoung.com
To learn more about Dr. Robert O. Young go to: https://www.linkedin.com/in/drrobertoyoung

Colloids and Colloidal Systems in Human Health and Nutrition

images-48

Abstract

Colloids and colloidal systems are essential to life. They are extremely useful, even indispensable, in many commercial and industrial situations as well. They function in every body cell, in the blood, and in all body fluids, especially the intercellular fluids, formerly known as “humors.” Therefore, increased understanding of colloids and their attendant phenomena, as well as the application of their operating principles, to enhance human health considerably is discussed in this article. Colloidal science is relatively young, however, and the number of qualified experts are few compared to other areas of science. In addition, most study in colloids has been confined to industrial processes. Having found use in agriculture, the concrete industry, horticulture, the floral industry, mining, electroplating and cosmetics, to name a few, colloids may have specific application in almost every form of human endeavor. Each of the few general areas just mentioned can be broken down into extensive subdivisions as discussed in this article.

[Key words: Colloids, Colloidal Chemistry, Colloidal Silver, Health, Nutritional supplements]

General Information

Definition of Terms

A material system in which one kind of matter, usually in the form of fine particles, is distributed more or less evenly throughout another is called a dispersion. The term colloid is usually applied either to a particle of matter falling within a specified size range, or to a colloidal system, which is a combination of particles and a containing medium, i.e., a dispersion. In this essay, colloid will refer to particles only, and colloidal system to the dispersion. A colloidal system may consist of one kind of colloid or a combination of solid, liquid or gas colloids dispersed in the medium. Essentially, particle size distinguishes colloidal systems from other material systems, such as suspensions and solutions (suspensions have larger particles and solutions have smaller.)

Classification of Dispersions

In 1925, H. Freundlich classified dispersions into three basic categories: true solutions, colloidal solutions, and emulsions/suspensions. There were four parameters for categorizing a dispersion: (1) particle size; (2) Brownian movement (movement of suspended particles resulting from the impact of molecules of the medium); (3) ability to pass through ordinary filter paper; and (4) level of solubility. Freundlich’s success in categorizing dispersions was somewhat limited due to the laboratory equipment available at that time. As a result, he and his contemporaries had to calculate the size of the particles. The table below identifies these categories of solutions.

Half a century later, the Russian scientist S.S. Voyutsky wrote his book on colloidal chemistry, and his findings.

is-matter-around-us-pure-chapter-2-class10-ncert-27-638

(Figure 1: The differences between suspensions, solutions and colloidal solutions)

Particle size was still of major importance in distinguishing systems from one another, but although the range of particle sizes in the diagram is the same as that originally calculated, the difference is that the emulsion/suspension level is divided into the microheterogeneous level (next up from colloidal) and the coarsely dispersed system. Voyutsky’s term for a true solution is the more accurate molecularly dispersed system, in which particles tend to be below 1 nanometer (nm). Though particle size is critical in making distinctions among systems, exact points of transition between the various degrees of dispersion cannot be established. Rather, there is a continuity much like the color transitions in a rainbow. Even so, colloidal systems are quite different from micro-heterogeneous ones, which do not have the very large total surface area of colloids.

In certain concentrations, micro heterogeneous systems display many of the same characteristics as colloids because a lot of the particles are within the colloidal range. However, due to the fact that a critical percentage of the particles are larger than 100 nm, a significant number of them will tend to settle. Micro-heterogeneous systems are a different color than a corresponding colloidal system. The color will tend more toward black because light is blocked by the coarser particles, and this will increase as concentration is raised. (See “Testing a Colloidal System” below.) Colloids may also be found in microheterogeneous systems and coarse suspensions. Relatively speaking, the total area of coarsely dispersed systems is quite small.

Colloidal Characteristics

Colloid size ranges from 0.001 to 0.1 micron (1 to 100 nm) in diameter. Since a micron is one-millionth of a meter, and a meter is about 40 inches, a micron is four one-hundred- thousandths of an inch. Thus, a colloid measures about four-millionths of an inch to about four one-hundred-millionths of an inch, or 10 angstroms at the smaller end of the range. This puts the size of the smallest colloids at about 10 times the size of a hydrogen atom.

Colloids do not settle, and are fdterable by ordinary techniques in the same sense as fdterable bacteria, whereas coarser particles in the dispersion size range are retained. They differ from “particles” in molecularly dispersed systems in that dispersed colloids cannot pass through the fine pores of passive membranes. Because of their size, colloids diffuse slowly.

In addition to particle size, a colloidal system must have the following three properties in order to be differentiated from other dispersions:

  1.  It must be heterogeneous, i.e., consist of dissimilar constituents, for example silver and water.

2.  It must be multiphasic, i.e., solid/liquid, gas/liquid, etc.

3.  The particles must be insoluble in the solution or suspension.

Each of these characteristics interacts with the others, giving a colloidal system its unique qualities. One fascinating thing is that even though particle size and concentration may vary, as long as most particles are in the proper range, the system will retain its colloidal properties, even though it may not be ideal.

Colloidal systems may be further identified according to the phases of their constituents. A solid dispersed in a liquid is called a sol, a solid or semi-solid colloidal system is a gel. An emulsion consists of one liquid dispersed in another. An aerosol, such as smoke or mist, consists of a solid or liquid dispersed in a gas. Some alloys are solid-in-solid colloids. The most common system, especially where human physiology is concerned, is the sol, or solid-in-liquid dispersion.

Sol Interaction

There are three main classifications of sols based upon the interaction of the particles and the medium:

(1) lyophobic (solvent-hating);

(2) lyophilic (solvent-loving); and

(3) association colloids.

Lyophobic colloids have little attraction for the medium and are therefore not highly stable (not able to remain dispersed). Metallic sols in water are examples of lyophobic colloids, that is, they lack the affinity for that medium. But they are atypical lyophobics due to the exceptional ability of metals to hold a charge. In lyophilic systems the particles are attracted to the medium. These systems are inherently more stable than lyophobic ones because the attraction of the colloid for the medium resists settling. Both types of colloidal systems are found in plant and animal fluids.

The molecules of association colloids have a hydrocarbon chain with a hydrophilic “head” group and a hydrophobic “tail” group. When dissolved in water the molecules form clusters called micelles. These keep the head groups in contact with the water while protecting the tails within the micelle from water. The interior of the micelle corrals oily material and keeps it stable within the system. Detergents and soaps are common examples of association colloids.

Surface Charge

The most important characteristic of colloidal systems is surface charge on the particles. Keep in mind that a “particle” is a group of bonded atoms or molecules. Charged particles repel each other, overcoming the tendency to aggregate (the attraction force) and remaining dispersed.  Particle size plays a major role in the capacity to bear a charge, and the colloidal size range is set by this capacity. In manufactured systems, the charge can be greatly increased over what might occur naturally. Within the range, the smaller the particle, the greater the surface and the greater the charge that can be applied in manufacture.  Only heterogeneous, highly dispersed colloidal systems, containing the smallest possible particles, have a well-developed surface area. Given a constant voltage applied to the system, particle charge is not automatically increased as the substance is made finer, but total charge in the system will increase.

Already coarse particles will tend to fall out even if they have received an electrical charge like the smaller particles, because gravity will have a greater influence than the electrical forces which maintain the dispersion. Metallic particles have a great affinity for each other at the atomic level. They are magnetically attracted to each other and want to bond. But the magnetism of metals does not create an added difficulty of attraction against maintaining a colloidal system because of the superior capacity of metals to hold a charge.

Given a constant particle size, the higher the concentration in a solution, the more likely the attraction force will overcome the repelling charge, creating larger masses. At some point, the mass will precipitate out due to gravitation. At lesser concentrations, the attraction force is insufficient for precipitative particle bonding, and groups are light enough that gravitation will not pull them out of solution. This is an ideal colloidal system.

Manufacturing Colloids and Systems

At least five methods were used to manufacture colloids before 1938, including: (1) Grind, (2) Wave, (3) Liquid, (4) Chemical, (5) Electrical. For medical or health purposes, the FDA now allows both the grind and electrical manufacturing techniques to be used. Of these two methods, however, the electro-colloidal process is generally considered to be far superior. (The chemical method, described below, is restricted to industrial or commercial applications.) With the grind method, the inorganic or organic particles are usually no finer than four one-hundred-thousandths of an inch, or about one micron, which is outside the upper end of the ideal size range by a factor of 10. Such particles may or may not be electrically charged. Even if a charge is present, the size of the particles may be great enough that the repelling forces are unable to overcome the pull of gravity. Thus, particles will tend to settle to the bottom of the solution, and much of the effectiveness of the colloidal system will be lost. While some sols owe their stability to particle size, charge and high dispersion, others employ a mechanical stabilizer added to the medium. Such stabilizers include gelatin, glycoproteins, and starch, among other things, which increase solution viscosity and cause the particles to settle much more slowly. The downside to this is that stabilizers tend to block the effects of the colloids, and the particles will still eventually settle if the solution is allowed to stand long enough. If the inorganic or organic particles are within the size range of 1 to 100 nm and are uniformly charged, no stabilizer is required to maintain suspension indefinitely in deionized water, as long as no disruptive influence intrudes. Thus, the integrity and power of a colloidal system is a factor of the interplay among size, charge, concentration, and interaction between particle and medium. It should be mentioned that shape is also a factor.

In recent years, the chemical process has been widely employed to replace the inferior grind method, because it provides a convenient shortcut to the more difficult electro- colloidal process. But it also has drawbacks, one of which is the difficulty in getting the chemicals (acids) back out of the colloidal solution. Consequently, traces of the chemicals are frequently left in solution, which can cause unwanted effects, especially in nutritional/medical applications. After studying the health benefits of various forms of colloidal silver, Dr. Leonard Keene Hirschberg, A.M.M.D. (Johns Hopkins) concluded, “There are two principal ways of producing metallic colloids, viz., chemical and physical (electrical). The two methods yield widely different results, and from a therapeutic point of view I need only deal with the electric colloid metals, since only these present the necessary homogeneity, minuteness of granules, purity, and stability.”

A simple illustration will suggest the immense power potential of a colloidal system. The total surface of a one-inch cube of iron is six square inches. By colloidal chemistry, the cube can be divided into particles having a total surface area in the range of 800,000,000 square inches, all expressing electrical energy. The total surface area of the particles in a quarter teaspoon is greater than that of a football field.

The Ultimate Colloid

The highest quality colloidal systems are produced by the electro-colloidal method, meaning the inorganic or organic particles and (usually) water have been completely “colloided.” This is simultaneous dispersion and bonding by a current sent through the combination. This is the only method that will create a true colloidal system by manufacture. Products that are simple mixtures of metal and liquid cannot possess nearly the potential of electrocolloids, and are therefore of questionable value. The proper electrical process allows inorganic or organic particles that are well within the colloidal size range to be drawn off an ingot. Animated by Brownian movement, they are able to remain in suspension in a liquid medium almost indefinitely. (Because many nutrients are best transported through the body in water, the best medium to use for ingested nutritional products is pure, de-ionized water.)

All other things being equal, the number of particles varies inversely according to the cube of the size change, so if size is reduced 50 percent, overall number is multiplied by eight. This is a mathematical proof, and is determined by actual count using an electron microscope and by atomic absorption. Obviously, ideal size is element dependent. Size is controlled by frequency, amperage and micro-meshes, among other things.

The ultimate colloidal sol contains ultra-fine and ultra-light particles in the range of 0.015-0.005 microns in diameter, and they will remain suspended in de-ionized water without need of any other ingredient. There is no visible accumulation of inorganic or organic particles either in the solution or settled on the bottom. Products that show visible particles in the solution or at the bottom of the container indicate that the particles are either too large or have not received the proper electrical charge.

The metallic particles in a sol may vary in concentration, but more is not necessarily better, unless we have correspondingly smaller particles. In fact, the reverse is usually true- less is better, and in essence, less is more, functionally speaking, because as noted earlier, the higher the concentration in a solution, the more likely the attraction force will overcome the repelling charge. But even before this happens, effectiveness is reduced. The highest quality colloid will have a certain maximum number of particles. They will be of the minimum possible size, and ideally no more than a “handful” of atoms hooked together per molecule of water utilized, and in a negatively charged state. This will prevent further aggregation at that size.

Testing a Colloidal System

A quick way to see if a solution contains colloids is by observing the Tyndall effect. A clear colloidal dispersion will appear turbid when a sharp and intense beam of light is passed through. The scattered light also takes on a cone shape within the solution. A simple way to observe this is to shine a very bright flashlight through a test tube of the dispersion in a dark room.

images-46

 

 

 

 

 

[Figure 2; Viewing the colloidal particle size of silver using a laser beam]

As noted earlier, a critical indicator of a colloidal system’s quality is its color. The ideal form of colloidal silver, for example, will have a golden yellow color. As the size of each particle increases, the color of the suspension proceeds from yellow to brown to red to gray to black. Therefore, the color range could also be read as “best to fair to mediocre to inferior.” In all cases, systems produced using the electro-colloidal method are a different color than those from other methods except where an artificial dye is used to imitate the proper color. Additionally, color varies with concentration, use of a stabilizer, and the presence or absence of other trace elements.

To confirm that a product is a true colloidal, examine the ingredients. If it contains an ingredient other than the designated colloidal particles, the product may not be suitable. If no additional ingredient is listed, but the product requires refrigeration, it means there is an ingredient in it that might spoil at room temperature. Properly prepared using the electro-colloidal method, a colloidal system requires no such ingredient. Needless to say, a product with instructions to shake before using is also quite suspect.

Colloids and the Living System

Humoral medicine died in 1863 as a result of the influence of the Virchow school. Cellular pathology tells only part of the story of disease. The colloidal integrity of the intercellular fluids, or humoral milieu, is the sine qua non of life itself. The state of health is present when there is unhindered flow of life- force through every part of the humoral system. The real function of body cells is to maintain the milieu in a state of functional efficiency.

-O.C. Gruner, M.D.

Colloid Pioneers

At the present time, colloidal chemistry plays a major role in over 7,000 industries, and, as noted earlier, most study in colloids has been applied to industrial processes. In the last few decades of the 19th century, and even well into the 20th, there was considerable awareness of the importance of colloids to human health. But with the rise and sway of monomorphic, allopathic, cell-oriented medicine, this area of study fell by the wayside. Therefore, there is currently comparatively little awareness of, or focus on, colloids in the living system. Professor Wolfgang Ostwald has noted, “All life processes take place in a colloidal system, and that is true both of the normal fluids and secretions of the organism, and of the bacterial toxins, as well as, in large measure, of the reactions which confer immunity.” Based on that premise, Alfred Searle wrote:

Fortunately, the recognition of bacteria and their products as essentially colloidal in character has greatly facilitated the study of disinfection. It is now realized that-disregarding the fact that bacteria are alive-they may, owing to their colloidal character and that of the toxins and some other substances they produce-be destroyed by substances which bear an electrical charge opposite to that of the bacteria or their colloidal products.  ” . . . The great advantage of dealing with germs as colloids lies in the fact that the agents used for their coagulation and consequent destruction are not necessarily poisonous . . ..”

Colloidal silver, for example, has no recorded side effects. Its power to “disinfect” stems from the frequencies of vibration presented on the surface of the particles; i.e., they are very highly charged oppositely to microorganisms, and very active. Yet they are completely safe and natural. It is a situation opposite to the antibiotic one, which is “toxichemical,” not only to the target microform but to the host as well, and which sets more improperly charged toxins free in the system rather than catalytic, energetically harmonious colloids. Moreover, the antibiotic cannot really alter the condition which supported the evolution of the target form, and may not even kill it but only instigate an evasive pleomorphosis and potentiate a worse scenario later. This is not to mention the negative effect on the health and vitality of the intestinal villi. (The intestinal villi are safe from colloidal silver because the silver is absorbed and/or used to buffer dietary acids in the mouth and stomach before reaching the small intestines and the intestinal villi.)

Alfred Searle:

Metal solids have the further therapeutic advantage of acting most rapidly in faintly alkaline solutions, so that when properly prepared they are not affected adversely by normal blood. Before a therapeutic substance can exert its full effect it must be converted into the ionized or into the colloidal state. . . . The drugs employed to combat disease should be in the colloidal state, i.e. in a form in which they may be isomorphic and isotonic with the elements of the body. Only so can they be expected to exert their full potency.

The task of thus bringing their remedial virtue to its highest point is not an easy one, for colloidal substances, unless prepared with consummate skill and meticulous care, lack stability, and are prone to precipitation when brought into contact with the electrolytes normally present in the body tissues and fluids.

Though Searle was speaking in terms of pharmaceuticals, the information also applies to food supplements.

Colloidal Behavior

Since surfaces present, and interact through, electrical and magnetic energies, the electrical characteristics of colloids take on fundamental importance. For example, sick, dead and broken-down cells are attracted to colloids by electromagnetic force, as iron filings are attracted to a magnet. The resulting complexes are carried into the lymph, which recycles what it can, while the rest are carried to the bloodstream to be eliminated. The recycling/breakdown process is carried on by a normal level of fermentation, and it is highly likely that (colloidal) microzymas provide the enzymes as theorized by French scientist and medical doctor,  Antione Bechamp.

The surface energies of colloids have powerful effects on physical and chemical activity. It is well known that like charges repel and opposite ones attract, thus surface charges on colloids maintain an energetic system that resists coagulation. Often behaving like enzymes in life processes, certain colloids act as catalysts in chemical reactions. The high surface energies that may accompany them account for the action and sensitivity of colloids in the living system. The electrical potential on the surface of a colloid is known as the zeta potential. Another colloid pioneer, Thomas Riddick, believed zeta potential to be a basic law of nature, or an expression of a universal law-the Law of Balance, or the tension of opposites. Nowhere is this law better represented than in positive vs. negative charge, the fundamental vibrations of elements. Thus, it becomes obvious that zeta potential is basic to life. But each substance, being uniquely configured, will present its own quality of influence.

Gotto-rouleau-300x225

(Figure 3; Red blood cell clotting know as Rouleau due to lost surface charge)

Blood Clumping (Rouleau)

These photographs show the blood of a healthy person after eating a large meal with a high fat content. The  picture in Figure 3 shows the red blood cells immobile and aggregated due to loss of surface charge or zeta potential. At this point the person felt tired and listless. Figure 4 picture is the same person’s blood 15 minutes after drinking a glass of alkaline water with 5 drops of liquid colloidal alkalizing minerals. (pH Miracle’s LiquidLightning Siver DepHense Minerals™ were used.)

mycoplasma-300x225

[Figure 4: The normal profile of red blood cells is to be separate residing in their own space]

These highly negatively charged particles impart a vibrational energy which breaks the cells apart and restores the zeta potential-what I call the negative spark of life. Blood cells are once again discrete and highly mobile, regaining their efficiency as carriers of oxygen. The subject reported feeling bright and energetic.

The Colloidal Computer

The human body is literally a gigantic liquid crystal!

-Robert O. Becker, MD

We know today that all living organisms are composed of highly structured colloidal systems and that these form the basis of a gigantic colloidal computer. Every cell has an internal colloidal system arranged in patterns to create specific functions. The cells surrounding nerve fibers-glial cells in the brain, Schwann cells in the rest of the body-are made up of high-zeta-potential colloids arranged in a structured matrix. (The reader may be aware that the difference between Einstein’s brain and ordinary brains is that his brain had more glial cells.)

Dr. Robert O. Becker, formerly of the Upstate New York Veterans’ Hospital, is considered the world’s foremost authority on electrically accelerated healing of tissues. In his book The Body Electric, he describes his discovery of an analog computer-type healing system in the body. (Until he made this discovery, it was thought that the nervous system was a digital information transfer system.) In an analog computer, information is transmitted by voltage levels or by current intensity. Becker found that glial and Schwann cells form the basis of a direct-current, analog healing system for broken bones. The body produces a negative electrical current across the break, which mediates the healing process-by attracting nutrient ions to the area, for one thing.

He also found that glial cells and Schwann cells are semiconductors just like transistors and that there is a direct correspondence between these cells and the acupuncture energy system mapped out by the ancient Chinese. (Despite his brilliance, however, Becker joins other pioneers in being ignored and shunned by establishment savants because his work threatened vested interests and carefully guarded concepts on several fronts. Thus, for one thing, a marvelous development of his-a safe, effective method of regenerative, scarless healing of severe injury-has been denied to the world.)

The body has a special mechanism-called, for convenience, the blood-brain barrier-that somehow prevents many substances from entering the brain. It is very likely an electro­chemical condition in which the balance of electrolytes in the brain and nervous system is critical. When the electrolyte balance is disturbed and the crystalline structure of this vital liquid changes, unwanted materials may pass the barrier. Since a colloidal system supports intercellular fluid, the same situation may exist here, so that if the colloidal system is compromised, the electrolytes lose their ability to reject unwanted substances.

Dr. Becker has shown that the “permeability” of the barrier is altered by external, pulsed electrical and magnetic fields of extra-low frequencies (ELF, or 1 to 100 Hz). ELF signals are transmitted by power lines and hundreds of industrial and household products. Everything from hair dryers, TV sets, computers, washing machines, clothes dryers, even electric wrist watches emit these low frequency waves. Dr. Becker believes the health and possibly the existence of the human race is threatened by these signals, as they alter the chemistry of life (an area in which he threatened money interests). Experiments have shown that colloidal dispersion is threatened with collapse by ELF signals when the zeta potential of the colloidal system is low. At this point it takes very little stress to trigger flocculation in the system. This occurs with most colloids at a zeta potential of around 1 millivolt.

Dead Zones

It is possible that the increase in zeta potential achieved by adding high energy colloids and anionic electrolytes to the body will protect us from these harmful energies. As noted, colloids and electrolytes relate to and support one another by their electrical bio-energy. Health is vitally characterized by organized matter that carries a high negative surface charge. Death/disease in the terrain is the neutralization of a colloidal system in an area of the body by the positively charged influence of toxins, residues from acid-forming food, and resulting morbidly evolved microforms and their acids. I refer to such areas as dead zones. They exist in the blood as rouleau, as fused cells in tissues, and in the intercellular fluid itself (see below). Toxins and debris in the system promote loss of negative surface charge and act as mortar to glue cells together, reducing function and efficiency. Given the chance, the body will deal with these areas in an electrical manner somewhat analogous to Dr. Becker’s revelations about broken bones. Here, however, the electricity is not a current, but is static. Highly negatively charged colloidal mineral particles will be attracted to these zones, exert their influence and re-establish balance, allowing blood cells to dissociate and opening up cellular communication in tissue. They do this by providing the “negative spark of life.”

Intercellular Fluid

A most crucial area for appreciating the signifi of cance colloids and their flocculation, is the intercellular fluid, or body humors. As described by O.C. Gruner, M.D., the flow of life is maintained in the space between cells, where the living system has enclosed part of the ocean, so to speak. This humoral milieu, or “lake” as Gruner refers to it, has inflow and outflow. The specialized cells of the “tissue spongework” rely upon this substance that bathes them, maintains pH, brings in nutrients, carries away wastes, and shields them from toxins. The flow moves from the capillaries through the interstitial spaces, then, after exchanges with the cells, back into the lymphatic channels.

Some remarks from Gruner:

“Unless the outlet of the pool is patent, and the canaliculi likewise, chemical changes take place in the stagnant fluid. Moreover, the parts beyond cease to receive the materials needed. . . . Should this movement be arrested in any part of the body, however small be the site, and however short be the time-what we call “disease” begins. … It may be some time before the signs of obstruction become evident. . . for the surplus capacity of the “lake” is so great. . . . We have this principle then: there is only one disease. All the 414 (or so) diseases described in textbooks of medicine are fundamentally forms of one and the same disorder …. The problem to be solved in every case of sickness is, “for what reason has the flow of intercellular fluid ceased, and in what site has it ceased?” But the final reason is the presence in the fluid of the “pathogen,” whose makeup is chemical [emphasis added].”

The pathogen is of course not a microform but a toxin. Nutritional deficiency, the other major pathogenic factor, must also be kept in mind.

Colloids and Inner Light

In emphasizing the importance of the dynamics of the lake, Gruner describes an “. . . .intangible circulation, . . . namely the flow of ‘vitality,’ life-force, bioenergy, along the neuro-endocrine system, following the physiological processes of absorption, assimilation, and elimination. As long as this flow is unhindered, the individual is in a state of health.” It is the extraordinary surface area of the colloidal system which makes it capable of carrying a high level of charge and thus vibrational energy, or bioenergy. The neuro-endocrine system, the neuro-lymphatic system and the muscular system are all tied together via the meridians identified by the Chinese over 5,000 years ago and used in acupuncture ever since. And the operating principle of acupuncture recalls the yogic understanding of prana (life force) and the chakras. The Law of Balance is again manifest as the yin and yang aspects of life force. Thus, in addition to food, the body ingests, assimilates and excretes subtle vibratory energies, including normally invisible light frequencies.

An interesting aspect is that Gruner sees both the lake and the lymphatics as vital sites of parenteral digestion. In the lymphatics: “There is a real digestion of the entering fluid carried on by the ferments [emphasis added] supplied by their cell population.” And in the intercellular fluid: “The ‘lake’ is the site of parenteral digestion. This is the real digestion. It is the site of constant building up and tearing down, through enzyme activity.” As indicated, poisonous waste products from dietary improprieties find their way into the fluid and interfere with the flow because they cannot be perfectly digested. They are “acid decomposition products,” which create a condition of anoxia in the fluid:

Besides this anoxia . . . the lack of ferment [emphasis added] needed to break up the pathological substances itself causes interference with the onward flow. . . . Failing the breakdown of the materials in question, deposition will occur. As Lumiere pointed out, it is not the chemistry per se that accounts for health, it is the due retention of the colloidal state [emphasis added]. When flocculation (precipitation, deposition) occurs, the signs of disease appear. … To sum up, the effects of interference are evident to the clinician in all the manifold forms which disease assumes. . . . Their real significance is appreciated in terms of biocolloidology.

What structure could be responsible for most or all of the critical fermentations and anabolic enzyme activity carried on in this inner sanctum? Our fundamental anatomical elements, the colloidal microzymas of the brilliant Antoine Bechamp? It is the electrical, or bioenergetic nature of the fluid that supports the flow, and it is primarily a colloidal system, in concert with (molecular) electrolytes, that constitutes its electrical nature. A fascinating point to be made with respect to anabolic activity is that Gruner believes the lake to be the birthplace of cells, which must also be the work of the tireless and indestructible microzymas .

With regard to the presence of light in living systems, recent discoveries indicate that colloids play a critical role in the vital function of intercellular communication.  Discoveries by Dr. Fritz Albert Popp of Germany indicate that the DNA molecule transmits its blueprint information to other cells by means of encoded bursts of ultraviolet laser light. The optical pathways for this information are “light pipes” consisting of highly structured cellular water {Fusion, Sept./Oct. 1985). Popp indicates that the structure of cellular water is created by minute quantities of highly charged colloidal minerals.

Applications in Health

In the billions of cells comprising tissues and organs, energy is obtained from certain metals, among them iron, iodine, manganese and copper. There are some 32 minerals in the body, with traces of at least as many others. Colloidal nutritional chemistry is the science which converts those elements into particles so minute they can be utilized directly by cells and the intercellular fluid.

Ideally, a nutrient should be administered in such a form that its essential constituent will travel through the body until it reaches the part where it is required, and that it arrives at that organ or tissue in such a state as to be used to the greatest advantage. To administer a substance in chemical form because it has been isolated from brain matter, for example, may be to misunderstand the chemical and physical changes which take place in assimilation, and thus to supply the material in a form from which it has to be converted. The fact that this conversion occurs shows how marvelous an alchemist the human organism is; but it is no reason for the administration of agents in less than ideal form, especially when the physiology is weakened. The treatment of a disease condition by the administration of various compounds is much more completely understood when it is realized that the reactions deal largely with colloidal materials and systems. Nutritional and remedial treatments become most efficient when they can be based entirely upon this principle or can include it, eliminating or minimizing further disturbance to the system.

Before the 1940s, even though certain colloids had seen substantial success-colloidal silver for example-the full health potential of colloids in general had not been demonstrated. This is due to a number of factors, of which the two most important are: (1) the difficulty of studying the special properties of substances in the colloidal state with the technology at hand in the first three decades of the 20th century; (2) failure of early investigators to realize the necessity of stabilizing the remedial colloid in terms of rendering it isosmotic with the blood serum, thus preventing precipitation. Then, in 1941 and later, antibiotics and other “miracle drugs” came on the scene, and mainstream interest turned away from the great potential of colloids. Thus, their potential has waited to outlive the devastation of health by drugs and has become more fully realized only in the last decade.

Stabilization

It is now quite evident that the application of colloidal sols to the disease condition of the human body is distinctly encouraging. As suggested, a supply of improperly prepared and unstable colloidal systems has been one of the most serious sources of drawbacks and discouragement. In sols, the presence of very small quantities of certain salts, the ions or ultimate particles of which have an electrical charge opposite to that of the active colloid, will coagulate the latter unless it is protected by some means. In this case, coagulation or precipitation can occur only when the protective agent has been destroyed or removed.

In the 1970s, upon recognition of the colloidal nature of the chief body fluids, German investigators saw the enormous possibilities for the application of colloidal disinfectants and medicines. Subsequently (1980s), several colloidal products were placed on the market and their therapeutic properties carefully and vigorously “hyped.” Most of these systems rapidly deteriorated in value, however. Some were so unstable they contained no active colloid at the time of use, and others, not being isosmotic with body fluids, coagulated immediately upon administration.

On the other hand, if a substance is converted to the colloidal state in the presence of certain other colloids and of certain salts, the activity of the desired colloid will not be impaired and the system will be quite stable, mixing easily with blood or other body fluids without being rendered inactive by them. A potential drawback is that, while the additional colloids and salts enable use under otherwise impossible circumstances, the action of the protective agents becomes a factor. Usually it appears to be negligible, but occasionally it has been observed to be of considerable importance.

Practicality

A great advantage which colloidal sols of elements possess over compounds is the facility with which their action may be studied. If a salt or other compound is administered, there is always the chance of it undergoing hydrolysis or ionization in the alimentary canal or bloodstream, thereby setting up a complex situation in which elements other than the one under investigation become involved. For example, iron may be administrated in the form of a carbonate which is converted  in the stomach into chloride and this, on dilution, is hydrolyzed so that eventually there are formed both hydroxide and chloride of iron. If the iron were administered as a colloidal element, these complications would be avoided and the investigator would be much more certain in drawing conclusions.

Also, an element in the ionized state is always associated with its corresponding ion(s). Thus, ionized potassium chloride separates into potassium ions and chlorine ions, and the net charge of the system is neutralized. When the element is administered in the colloidal state, however, it is introduced alone as an active agent, the charge in the particles is quite definite, and activity is correspondingly great. Also, the extreme toxicity of many combined or non-colloidal elements is avoided when administered in the form of colloidal sols, while usefulness is brought to the fore. The remarkable fact that colloidal silver and iodine do not stain the skin, whereas pharmaceutical preparations of silver and iodine do so strongly, is a further indication of the striking difference between colloidal sols and ordinary solutions.

The effect of administering elements in a colloidal state to persons suffering from certain symptomologies is extremely interesting, partly because of the progress of the recovery, and partly because of the absence of complications such as occur when the same element is administered in another form. Consequently, there is much truth in the statement that a substance to be fully efficient must be in a colloidal state, or very easily convertible to it in the body of the subject.

Power

Many metallic colloids serve as powerful catalysts. For example, colloidal silver, titanium, gold, platinum, rhodium, iridium, osmium and palladium are effective catalysts in the despecialization and respecialization of cells. I have observed that these highly negatively charged metal sols can cause red or white blood cells to dedifferentiate to their embryonic state and then redifferentiate into cells needed due to emotional or physical stresses, e.g.,. bone, muscle, nerve or skin cells. This phenomenon was seen in a patient with third degree burns on his hands and face. As silver and titanium metal sols were administered topically, new skin grew rapidly through the respecialization of blood cells. Even where there were skin grafts, new skin was created underneath them, where the metal sols were administered. In The Body Electric, Dr. Becker also reports observations of the healing power of the negative charge.

The electrically charged particles of some metal sols have activity and catalytic power so great as to be barely conceivable. They can induce chemical reactions which would otherwise require conditions unattainable in the human subject. Dr. Hirschberg found that they cause strong chemical actions “out of all proportion with the quantity of matter brought to bear.” Marked catalytic properties are evident when only 0.0000002 grain of a platinum sol is present, for example. This intense power of promoting reactions and of being themselves left free at the end of the reaction results in very small quantities of metal sols being capable of effecting changes highly disproportionate to the amount of sol present. Changes which are extremely complex or which would otherwise require a long time if relying on a series of successive reactions may be readily effected by the presence of an elemental sol. These considerations throw light on the importance of trace elements in nutrition. Metal sols have the further therapeutic advantage of acting most rapidly in slightly alkaline solutions, so that when properly prepared they are not affected adversely by normal blood.

Of interest is the fact that substances (e.g., mercuric chloride or arsenic acid) that block catalysis by metallic colloids, have a like effect on biological systems-that is, they block biochemical reactions and hence can be lethal.

Conclusion

The use of specific colloids in health is not a universal cure-all, but just as the administration of extracts or isolates marks an advantage in many cases over the use of the cruder source, so the employment of colloidal elements marks a clear step forward in many cases over traditional supplements or remedies. The ability to energize blood and body fluids alone offers major support to health and a means of addressing a fundamental physiological dysfunction. From this standpoint, the positive effect of colloidal supplements on a host of symptomologies could be anticipated, and has been observed clinically.

General References

  1. Alexander, J. Colloid Chemistry. New York: Van Nostrand Co., 1924.

2.  Becker, Robert O., M.D. and Selden, Gary. The Body Electric. Electromagnetism and the Foundation of Life. New York: QuillAVilliam Morrow, 1985.

3.  Becker, R.O. and Spadaro, J.A. Treatment of orthopedic infection with electrically generated silver ions. Journal of Bone and Joint Surgery, January 1978; 60-A: 871-81.

4.  Becker, R.O. and Spadaro, J.A.. Experience with low current silver electrode treatment of nonunion. In: (Grighton, Carl T., Black, Jonathan, and Pollack, Solomon, eds.). Electrical Properties of Bone and Cartilage. New York: Grune and Stratton, 1979, pp. 631-38.

5.  Freundlich, H. Colloid and Capillary Chemistry (H.S. Hatfield, translator). New York: E.P. Dutton and Company, Inc., 1922.

6.  Freundlich, H. The Elements of Colloidal Chemistry (G. Barger, translator). London: Methuen & Co. Ltd., 1925.

7.  Goddard, E.D. Colloid. In: The World Book Encyclopedia, Vol. 4. Chicago: World Book, Inc., 1985.

8.  Gruner, M.D. and Cameron, O. An Interpretation of Cancer. Montreal, 1947. Reprinted Pomeroy, Washington: Health Research, 1973.

9.  Higher Education Library Publishers (H.E.L.P.). Colloidal Silver-A closer look. H.E.L.P.fulNews, Vol. 9, p. 11.

10.  Hirschberg, Dr. Leonard Keene. Electrical Colloids, from an article out of Johns Hopkins University Hospital.

11. Searle, A.B. The Use of Colloids in Health and Disease. New York: E.P. Dutton & Co.,1919.

12. R.O.  Young, Sick and Tired, Reclaim Your Inner Terrain. Woodland Publishing, Orem, Utah, 1999.

13.  R.O. Young, S.R. Young, The pH Miracle revised and updated.  Hachette Publishing and Grand Central Publishing, New York, New York, 2010.

14.  Voyutsky, S. Colloid Chemistry (N. Bobrov, translator). Moscow: Mir Publishers, 1978. Webster, D.A., Spadaro, J.A., Becker, R.O., and Cramer, S. Silver anode treatment of chronic osteomyelitis. Clinical Orthopedic and Related Research, 1981; 161: 104-14.

A Finger on the Magic of Life-Antoine Bechamp, 19th Century Genius (1816 – 1908)

images-41

The Magic Eraser

There have been several notable occasions in history when persons offering invaluable contributions to the advancement of human understanding have been ignored, ridiculed and even persecuted in their time. In most cases, however, their work has subsequently been given a deserved measure of recognition. Some great ones, though, have not enjoyed such rejuvenation and have “suffered the slings” of obscurity.

So it is with Antoine Bechamp. Had the profound voice of his science not been silenced, much of humankind may have been spared the worst aspects of the infectious stresses of the 20th century. Since the case can be made that the approved but improper and dangerous treatment of infectious “diseases” over the last century has in large part given rise io the present epidemic wave of degenerative “disease,” including cancer and AIDSyndroine, we might have been spared these miseries as well. At the least, we would have understood much more clearly why we have them. Fortunately, however, Bechamp’s work has been kept alive by small, successive bands of truth-seekers.

The adoption by science of Louis Pasteur’s germ theory as the whole truth, without regard to the subtleties and deep insight of Bechamp’s microzymian principle, represents one paraphrased: “There is no medical doctrine so potentially dangerous as a partial truth implemented as whole truth.” Any medical professional, bioscientist, health care practitioner, or lay person for that matter, who wishes to gain insight into the origins and nature of infectious and chronic illness, against the backdrop of a marvelous view of the life process, must consider Bechamp. And they must entertain one of the most important concepts to come out of his illustrious career-microbiological pleomorphism as it relates to disease and its symptoms.

There are four books written about him of which this writer is aware (although there are very likely more) and many works published by him. Of the ones by him, all except one are in the original French. Fortunately, his last book, The Blood and Its Third Anatomical Element, was translated into English in 1911 by Montague R. Leverson, M.D., Ph.D., M.A., although it has been difficult to obtain. Of the two major books about him, one is in French and the other (E. Douglas Hume’s Bechamp or Pasteur?) is also rare. The other two books about Bechamp are by R.B. Pearson. The Hume book, one Pearson book, and The Blood are once again available as reproductions in the U.S. after a hiatus of several years.

Bechamp considered The Blood his crowning work, and therein he describes an amazing microanatomical entity and its participation in the clotting process. He also includes details of his work and his experiences with the plagiarisms and “pettifogging ratiocinations” of Louis Pasteur. The French book about him, which author Christopher Bird praised highly to this writer, is by Marie Nonclercq, entitled Antoine Bechamp, 1816- 1908: L’Homme et le Savant, Originalite et Fecondite de Son Oeuvre. The latter part means, The Man and the Scientist, the Originality and Productivity of His Work. According to Bird, in an account given at a 1991 facts that did not set well with reigning theory, many questions arose … as I read essays and books, of a heretical nature, one could say, written by researchers whose names I never heard mentioned in my classes.  

Twenty years ago, the World Health Organization proudly declared recently the discovery that the single greatest factor in heart disease is a vitamin E deficiency.

Also perversely awe-inspiring is the fact that a person of Bechamp’s extraordinary accomplishments has been written out of history books, textbooks and all encyclopedias. It is sobering to consider the required degree of authoritarian control over key academic elements in our culture. It is not my intention to belabor the politics, but as the wonders of Bechamp’s work unfold to the mind, the question simply arises, “Why is this not common knowledge?” Yet, we must be grateful that his “erasure” was far from complete.

It is difficult to do full justice to Bechamp without recourse to a book. His work was incessant and prodigious, and his observations prolific. I will attempt to convey some essentials of his biological work-only a part of the picture, as the total output includes chemistry, medicine and pharmacy. He left a remarkable legacy of scientific insight that borders on the spiritual, yet died in relative obscurity with virtually no recognition by peers or the public. Having outlived his wife, his beloved associate Professor Estor, and his four children, he had to endure those hard lessons of life in addition to the one of professional anonymity. However, in keeping with his extraordinary mind, he never lost conviction that the truth would come to light, as would his role in its revelation.

I’m not sure why, when his life touched mine through E. Bechamp is known among a coterie of modern and contemporary admirers, and his work has been followed up, knowingly or not, by perhaps a total of 50 scientists. This group includes such names as Gunther Enderlein; Wilhelm Reich; Royal Raymond Rife; the courageous Australian team of Glen Dettman, Ph.D. and Archie Kalokerinos, M.D. (who for many years published information in the Toorak Times, an Australian newspaper); and Gaston Naessen, including myself, who have brought the Bechampian locomotive to a full head of steam.

It is at once unbelievable and understandable that the superficial dogma of Louis Pasteur could have prevailed over Bechamp’s insights in the 19th century French Academy of Science. Unbelievable because of the meticulous documentation and presentation Bechamp made of his prolific work. Understandable because Pasteur stole enough of the truth to make it pass, while having on his side upper class connections and a doctrine that more suited the cultural (especially religious) moods of the time. Abetting, if not creating, an atmosphere repressive to truth was a mood of impassioned ignorance among ecclesiastic authorities at the University of Lille, where Bechamp had moved in 1875 to teach. In a manner similar to that which devastated Galileo, they vigorously opposed the “heresy” of the microzymian view. Heightening the poignancy of this tragedy was the depth of that ignorance, which was unable to realize that the view was not heretical at all. In fact, Bechamp was a devout Christian who felt his inquiries merely to be revealing the Creator’s modus. But it is perversely awe-inspiring to see such bias having persisted for a century, supported by the structure of authority in bioscience, so that Bechamp’s principles have not yet (2015) been given fair examination in the mainstream.

Things may soon change-for a number of reasons, not the least of which is that research in the medical literature is now burning a raging blaze below the lofty suite in which the few powerful controllers lurk. They will soon have to surrender themselves at the window, or be consumed by the flames. Of course, one way in which they surrender is to rediscover the truth, that is, claim credit for making scientific “discoveries” about matters long ignored or repressed by them and long held as principle in alternative venues. For example, “science” has just discovered that antioxidants are good for asthma, especially vitamins C and E. And after the tireless, definitive work on vitamin E by the Shute brothers probably 20 years ago, the World Health Organization proudly declared recently the discovery that the single greatest factor in heart disease is a vitamin E deficiency.

Also perversely awe-inspiring is the fact that a person of Bechamp’s extraordinary accomplishments has been written out of history books, textbooks and all encyclopedias. It is sobering to consider the required degree of authoritarian control over key academic elements in our culture. It is not my intention to belabor the politics, but as the wonders of Bechamp’s work unfold to the mind, the question simply arises, “Why is this not common knowledge?” Yet, we must be grateful that his “erasure” was far from complete.

It is difficult to do full justice to Bechamp without recourse to a book. His work was incessant and prodigious, and his observations prolific. I will attempt to convey some essentials of his biological work-only a part of the picture, as the total output includes chemistry, medicine and pharmacy. He left a remarkable legacy of scientific insight that borders on the spiritual, yet died in relative obscurity with virtually no recognition by peers or the public. Having outlived his wife, his beloved associate Professor Estor, and his four children, he had to endure those hard lessons of life in addition to the one of professional anonymity. However, in keeping with his extraordinary mind, he never lost conviction that the truth would come to light, as would his role in its revelation.

I’m not sure why, when his life touched mine through E. Douglas Hume’s historical biography, such a strong feeling arose in me-the need to “exonerate” him, to bring his name and work to their deserved place of honor in history. Part of it, I’m sure, as with M. Nonclercq, is realizing the health benefits society might reap from understanding him, not to mention the inspiring, if not magical, insight into life and being that his views represent. But I’m still not quite sure why I want to be able to say (if in some way my various expositions about him over the last decade, added to the voices of others who have seen with his eyes, contribute to open re-evaluation of his science), “There, Antoine! Rest in peace, my friend.”

Principles of Micromorphology

While some of the ideas Bechamp addressed predated him, they had not been so clearly described, fully developed, or strongly supported by experimentation. It is said there is nothing new under the sun. If true, it may be because all things, or situations, exist at once in the Creation. It is a matter of perspective, much like looking at a tapestry. Bechamp’s perspective allows us to step back from tight focus and see the loose threads of the germ theory amidst a harmonious and astounding pattern of the life process. He had his “finger” on the magic of life. According to Hume, the essence of what he brought to us was as follows:

First, he demonstrated that the air is filled with microscopic organisms capable of fermenting any suitable medium on which they happen to land. He showed that the chemical change is carried out by a soluble ferment produced by the organism, and this ferment is analogous to the digestive juices of the stomach. Thus, he identified fermentation as a digestive process. (Dr. Young theorizes that all decomposition, even the rusting of steel, is mediated by ferments. It is known, for example that bacteria decompose rock into soil. Microorganisms are at or near the foundation of all life and life processes on Earth. For example, fungal forms are indispensable parts of the roots of most plants, including the largest trees.)

Secondly, the most profound conclusion to which Bechamp’s untiring and painstaking research led him is that there is an independently living microanatomical element in the cells and fluids of all organisms. This element precedes life at the cellular level, even the genetic level, and is the foundation of all biological organization. What originally piqued Antoine’s procreative curiosity was the discovery, somewhat by accident, that pure chalk from geological deposits at least 11 million years old would liquefy starch and ferment sugar solutions, while man-made chalk would not. After years of work tracking down the cause (fermentation was not understood at the time), he attributed the action to the living remains of organisms long dead. He called this tiny living element a “microzyma,” or small ferment.

Thirdly, he claimed that microzymas routinely become forms normally referred to as bacteria, and that bacteria can revert or devolve to the microzymian state. (This is the principle of pleomorphism, which is central to understanding the appearance of “infectious” and degenerative disease symptoms in the body.)

Fourthly, he explained that atmospheric germs are not fundamental species, but are either microzymas, or their evolutionary forms, set free from their former vegetable or animal habitat by the death of that “medium.”

Bechamp explained: “The microzyma is at the beginning and end of all organization. It is the fundamental anatomical element whereby the cellules, the tissues, the organs, the whole of an organism are constituted.” He referred to microzymas as the builders and destroyers of cells. The quotation emphasizes the constructive aspect of microzymian activity and purpose, but it is the destructive aspect, or the “end of all organization,” which concerns us in disease. He always found microzymas remaining after the complete decomposition of a dead organism, and concluded that they are the only non-transitory biological elements. In addition, they carry out the vital function of decomposition, or they are the precursors of beings (bacteria, yeasts and fungi) which do so. Thus, he clearly presented the idea that the physical life of higher biological forms arises from, is dependent upon, and is recycled by, microscopic beings. Simple, immediate proof of dependence is the indispensable bacterial population in the human GI tract. And it adds piquancy to the whole matter to consider that our digestive and metabolic associates are plants.

The crucial “catabolic” aspect of microzymian behavior enters the picture when the body becomes diseased, for, according to Bechamp:

In a state of health, the microzymas act harmoniously and our life is, in every meaning of the word, a regular fermentation. … In a condition of disease, the microzymas which have become morbid, determine in the organism special changes . . . which lead alike to the disorganization of the tissues, to the destruction of the cellules and to their vibrionien evolution during life.

The microzyma is an organized (insoluble) ferment: a living element. Controlled fermentation is a vital physiological process. For example, it is utilized as a means of breaking down toxins in intercellular fluid and the lymphatics. Also, some commercial dietary fiber products contain acacia and slippery elm. These soluble fibers ferment in the gut, resulting in short-chain fatty acids such as butyrate and acetate, which are highly beneficial to the colon wall. Bechamp published a paper (still in French) about the role of microzymas in the production of salivary diastase (ptyalin). Since there are microzymas in every cell, in the blood and intercellular milieu, it is likely that many vital substances, mostly enzymes, are produced by them or by their complexes.

Bechamp said that the process of cellular breakdown is mediated by microzymian fermentation-even in a healthy body. Though there is renewal happening as well, breakdown fermentation (aging) eventually takes over, greatly increasing in intensity upon death. When oxidative metabolism ceases and a body dies, negative surface charges are lost and the terrain goes acid. Microzymas respond to biochemical signals, the most important being pH. The condition of disease is a milieu which presents to the microzymas a premature biochemical signal that the organism is dead. They consequently change their function and evolve into forms capable of more vigorous fermentative breakdown-forms that reflect disease-what Bechamp called “morbidly evolved microzymas.” If the host pays no attention while it is still feasible to adjust, s/he will be recycled sooner than would otherwise be the case.

And further:

“… In disease, it is the elementary tissues or cellules that are affected….

It should result therefrom that tissue and cellular pathology are in reality microzymian pathology. In disease, the cellules have been seen to change, be altered and destroyed, and these facts have been noted. But if the cellule were the vital unit living per se, it would know neither destruction nor death, but only change. If then the cellule can be destroyed and die, while the microzyma can only change, it is because the microzyma is really living per se, and physiologically imperishable, even in its own evolutions, for, physiologically nothing is the prey of death; on the contrary, experience daily proves that everything is the prey of life, that is to say, of what can be nourished and can consume.”

Further Conclusions by BeChamp

“That there is produced in the organisms of all living beings, including man, in some part and at a given moment, alcohol, acetic acid, and other compounds that are the natural products of the activity of organized ferments, and that there is no other natural cause of this production than the microzymas of the organism. [Emphasis added. Here is where, in a compromised terrain, the culminate forms described by Dr. Young in the main text of his book Sick and Tired, could play a role. As described by Bechamp-i.e., in an apparently healthy organism-it would likely be the initial development phase.] The presence of alcohol, acetic acid, etc. in tissues reveals one of the causes, independent of the phenomenon of oxidation, of the disappearance of sugar in the organism, and of the disappearance of the gluco-genic matters and that which Dumas called the respiratory foods.”

“That, without the concurrence of any outside influence except that of a suitable temperature, fermentation will go on in a part withdrawn from an animal, such as the egg, milk, liver, muscle, etc., or, in the case of plants, in a germinating seed, or in a fruit which ripens when detached from the tree, etc. The fermentable matter that disappears earliest in an organ after death is the glucose, gluco-genic matter or some other of the compounds called carbohydrate, that is to say respiratory food. And the new compounds that appear are the same as produced in the alcoholic, lactic acid and butyric fermentations of the laboratory; or, during life, alcohol, acetic acid, lactic or sarcolactic acid, etc.”

“That the microzymas, after or before their evolution into bacteria, attack albuminoid or gelatinous matters only after the destruction of the … carbohydrates.”

“That the microzymas and bacteria, having effected the transformations before mentioned, do not die in a closed apparatus in the absence of oxygen; they go into a state of rest, as does the beer yeast in an environment of the products of the decomposition of the sugar, which products it formed.”

“That . . . the necessary destruction of the organic matter of an organism is not left to the chance of causes foreign to that organism, and that when everything else has disappeared, bacteria-and finally the microzymas resulting from their reversion-remain as evidence that there was nothing primarily living except themselves in the perished organism. And these microzymas, which appear to us as the residuum of what lived, still possess some activity of the specific kind that they possessed during the life of the destroyed being.”

Microzymas Unique to Each Organism and Organ

The microzymas were too minute to differentiate with the microscope (even for today’s equipment), and Bechamp knew he was not going to see them in detail. His brilliance shows again, however: “The naturalist will not be able to distinguish them by description, but the chemist and also the physiologist will characterize them by their function.” Having masterful skill in chemistry, he utilized that ability, accompanied by ingenious use of the polarimeter, to draw many of his conclusions. He was led to conclude that an organism’s microzymas are unique to it, and are not interchangeable with those of another. He went further to say that even within a single organism, each organ and tissue has functionally unique microzymas, and that, for example, those of the kidney do not belong in the liver. What, therefore, did he have to say about inoculation?

The most serious, even fatal, disorders may be provoked by the injection of living organisms into the blood; organisms which, existing in the organs proper to them, fulfill necessary and beneficial functions-chemical and physiological-but injected into the blood, into a medium not intended for them, provoke redoubtable manifestations of the gravest morbid phenomena.

“. . . Microzymas, morphologically identical, may differ functionally, and those proper to one species cannot be introduced into an animal of another species, nor even into another center of activity in the same animal, without serious danger.”

How much more foolhardy is it then, when vaccinal microzymas are not only from another species, but are already morbidly evolved and are accompanied by preservatives, formaldehyde, and other chemicals? There is no sanity whatever to this practice. The best that can be said about it is that it may prevent, against the odds, the appearance of varying sets of symptoms. But this is at the price of weakening the immune system, toxifying the body, and possibly setting the stage for degenerative symptoms later in life-all the while doing absolutely nothing for, except perhaps worsening, the underlying disease condition.

As indicated in the above quotation concerning “granulations of the protoplasm,” it would seem that microzymas are also closely related to, and perhaps precursors of, genetic molecules. In an August 8, 1977 address to the (now defunct) International Academy of Preventive Medicine, Drs. Dettman and Kalokerinos had the following to say:

“It became increasingly apparent to us that the problems relating to infection and immunization were, to say the least, oversimplified by organized medicine. Perhaps Bechamp was thinking in advance of our modern molecular biologists who refer to genes controlling enzymes! We wondered whether Bechamp’s writing anticipated, in some respects, the discovery of RNA and DNA? It now appears to us that the experimental data described in Bechamp’s work has, in part, been independently and unknowingly repeated by Professor Bayev of the USSR Academy of Sciences.”

In a personal communication with Prof. Bayev (1974) concerning the common factors of his and Bechamp’s work, Bayev states:

“Self-restoration of the molecule from its parts was obtained with pure transfer RNA from baker’s yeast. It is a rather simple organic substance of molecular weight 30,00 daltons. Its chemical structure is now identified exactly. I think the microzyma by Bechamp has a more complex chemical nature than a simple organic molecule, but our experiments with transfer RNA molecules prove that self-restoration is possible already at the molecular level.” [Emphasis added.]

Finally, might we not ask ourselves how much our uncritical acceptance of Pasteur’s work has retarded the development of medical science to this day? In our own work we found that when we became aware of Bechamp’s arguments we were better able to understand some of the puzzles of ourfindings with Aboriginal infant death in Australia, which initially led us into conflict with the prevailing medical models of disease and immunization. We feel that we have gone too far to turn back, and that we need the help of all health care professionals who dare to think for themselves in working through the tangled web of relationships that govern disease-immunization- nutrition interactions.

Bechamp and Pasteur

Bechamp never denied that the so-called germs of the air or other causes may be contributory, either to decomposition or illness, but only that these have not been expressly created, nor are they needed, for these purposes. As noted, the germs of the air are nothing other than microzymas or their evolved forms from fermentatively destroyed organisms. Their destructive or morbid influence may be added to that already faced by the organism’s endogenous microzymas, which may or may not have initiated morbid evolution. This is a crucial departure from germ theory. That is, without the predisposition of inherent microzymas-which condition is engendered primarily by a faulty internal environment-the germs of the air, or those of other sick bodies, will not produce illness in a person. One can see how this holistic view confers responsibility and power on the individual, as opposed to making him a victim to be saved (by a medical science powerless to do so). In addition to microzymas in the atmosphere, “The spores of the entire microscopic flora may intrude, as well as all the molds that may be born of these spores.”

In the earlier phase of his career, as Professor of Medical Chemistry and Pharmacy at the Faculty of Medicine at Montpellier University, Bechamp and his tireless colleague Professor Estor had many opportunities to test microzymian theory in practice. Examination of an amputated arm and many examinations of frozen plants during a particularly cold winter, convinced them that upon injury, bacteria developed internally without any outside influence. Bruising an apple without breaking the skin is an example; the broken cells will autoferment. This is one basis for the surgical cleaning of wounds.

Pasteur, on the other hand, a non-physician and proponent of the germ theory, seems to have lacked a certain understanding of living systems. He considered the body to be a collection of inert chemicals, and therefore after death he expected nothing living in it. When life would inevitably appear in dead organisms, he had to draw the conclusion that it resulted from invasion from without by the beings whose existence had been taught to him and the world by Bechamp. Either he saw but would not admit, or he simply could not fathom, that microorganisms are already inherent to humans and every other organized medium on the planet, all of which contain, are composed of, and have developed from, microzymas. Unfortunately, the persuasiveness of Pasteur’s superficial conclusions held sway over the deeper, rather elusive, complex, profound, even mystical workings of life and pathology.

Bechamp:

Long before Davaine considered the inside of the organism to be a medium for the development of inoculated bacteria, Raspail said,

“The organism does not engender disease: it receives it from without..

. . Disease is an effect of which the active cause is external to the organism.” In spite of this, the great physicians affirm, in Pidoux’ happy words, “Disease is born of us and in us.”

But M. Pasteur, following Raspail . . . maintains that physicians are in error: the active cause for our maladies resides in disease-germs created at the origin of all things, which, having gained an invisible entry into us, there develop into parasites. For M. Pasteur, as for Raspail, there is no spontaneous disease; without microbes there would be no sickness, no matter what we do, despite our imprudences, miseries or vices! The system, neither new nor original, is ingenious, very simple in its subtlety, and, in consequence, easy to understand and to propagate. The most illiterate of human beings to whom one has shown the connection between the acarus and the itch understands that the itch is the disease of the acarus. Thus it comes about that it has seduced many people who give unthinking triumph to it. Above all, men of the world are carried away by a specious, easy doctrine, all the more applicable to generalities and vague explanations in that it is badly based upon proved and tried scientific demonstrations.

Much of Pasteur’s refusal to accept microzymian theory may have arisen from pure rivalry which came into focus when Bechamp solved, right under the Pasteur’s nose, a disease crisis threatening the French silkworm industry. Since the two must have known each other previously, we must be open-minded enough to allow that Bechamp, though concerned for his country’s important industry, may have indulged himself in a little one- upmanship in his embarrassment of Pasteur, who gained more privilege from social connection than from earned merit (thus, in most books, Pasteur is given credit for solving the crisis). If so, it may have cost Bechamp dearly, because it earned him the eternal resentment of the volatile chemist, who took every future opportunity to oppose his tormentor. And it was primarily the “specious easiness” of germ theory that allowed Pasteur to get away with it, because few scientists of the time were sufficiently skilled to probe deeply enough beneath the superficialities. Few possessed enough knowledge or insight to understand the elusive complexities. And Bechamp warned against facile judgments when he wrote in 1869:

“In typhoid fever, in gangrene, in anthrax, the existence has been proved of bacteria in tissue and in the blood, and one was very much disposed to take them for granted as cases of ordinary parasitism. It is evident, after what we have said, that instead of maintaining that the affection has had as its origin and cause the introduction into the organism of foreign germs with their consequent action, one should affirm that it only has to do with an alteration of the function of the microzymas, an alteration indicated by the change that has taken place in their form.”

Again:

“An egg contains nothing organized except microzymas; everything in the egg, from the chemical point of view, will be necessary for the work of the microzymas; if in this egg its ordered procedure should be disturbed by a violent shaking, what happens? The albuminoid substances and the bodies of fat remain unchanged, the sugar and the glycogen disappear, and in their place are found alcohol, acetic acid and butyric acid; a perfectly characterized fermentation has taken place there. That is the work of the microzymas, the minute ferments, which are the agents and the cause of all observed phenomena. And when the bird’s egg has accomplished its function, which is to produce a bird, have the microzymas disappeared? No, they may be traced in all the histological elements; they pre-exist-one finds them again during the functioning and the life of the elements; one will find them yet again after death; it is by them that the tissues are made alive.”

“The part of organized beings essentially active and living, according to the physiologists, is the granular protoplasm. We went a step farther and said it is the granulations of the protoplasm, and though for their perception a sort of spiritual insight is required, we have based our conclusions upon experimental proofs of the most varied and positive nature. Bichat looked upon the tissues as the elements of the bodies of higher animals. With the help of the microscope, very definite particles, cells, were discovered, and were regarded in their turn as elementary parts, as the last term of the analysis. . . . We have said in our turn: The cell is an aggregate of a number of minute beings having an independent life, a separate natural history. Of this natural history we have made a complete description.”

Bechamp apparently had a good sense of place in the scientific pursuit (“in our turn”) of the ever-retreating Ultimate Secret. He realized that the truth of empiricism is for the time, or is in the process of evolving. No doubt he would willingly have given up microzymian theory in face of right evidence of a newer observation. I am presenting science with a newer, though highly correlative, observation. For, as Bechamp attributed all fermentation in the body to microzymas, we now are able to see that it is also carried out by higher evolutionary forms-yeast and fungus. He would have been open to the idea that bacteria also evolve, and that there may even be a step or two between microzymas and bacteria, e.g., viruses. However, as I have suggested,  functionally the virus form is very likely something other than what it is thought to be in the mist-ified Pasteurian version of bioscience.

In this article the distinction has repeatedly been made between the disease condition and its symptoms. This idea is inherent in microzymian principle, and it is interesting that Bechamp alludes to the source of the disease condition as “imprudences, miseries or vices.” This is a close approximation in different terms of the holistic gamut of precursors to physiological ill-being: improper diet, emotional upheaval and various self­destructive behaviors. Yet it is a testimony to the power and skill of the propagandists of mainstream medicine and the Pasteurian decalogue itself that serious illness remains such a mystery in the mind of the masses.

Cosmic Microzymas

It is also interesting to hear the scientist speak of “spiritual insight.” And it is interesting as well to consider microzymas in terms of Eastern modes of spiritual thought, such as yoga, in which it is felt that our creation is an ongoing process. That is, life was not put here and simply proceeds, but it, and we, are coming into being in the moment. Thus, there is constant “turnover,” or renewal and healing. In this scenario, the microzyma may be seen as an early, if not the primary, transmutation from the fine vibrations of the Cosmic Life Force into a denser form or pattern of life-something not explainable by biochemistry, certainly. Due to the colloidal nature of these nascent elements, they carry high levels of energy and may also be receptive to frequencies of light and radiation asactivating or informational signals. During formation, or once formed, they may be stimulated by cosmic energy, which comes directly into our being, which provides energy that cannot be accounted for in the Krebs cycle, which is ionizing, and which has been interpreted as carrying part of the holographic human archetypal information. Is the microzyma Colloidal Intelligence, or a modus of the Creative Intelligence-a living transducer for the Idea in Consciousness, which it translates into the cellular anatomy? It was said earlier that microzymas respond to the pH of the surrounding medium, reforming when appropriate. However, the chemical aspect may be just an obvious way for us to qualify the situation. Perhaps the change in pH alters vibrations or resonant frequencies, changing the microzymian quality of reception, transmittal or transduction of the Life Force and cosmic rays. 

Bechamp said the microzyma is imperishable. Canadian microscopist Gaston Naessens says his analogous somatid particles have survived carbonizing temperatures, 50,000 rems of radiation, and all acids. If these claims are true, could such imperishability stem from being at the interface of energy/matter and Consciousness, i.e., from the imperishability and constant materialization of life itself? It may therefore be that only the Mystery of life stands prior to the microzymian patterns.

Elaborate Colonies

An interesting corollary to microzymian principle is the idea presented by Lynn Margulis and Dorion Sagan in their book Micro-Cosmos-that all higher forms of life are elaborate colonies of microforms that have undergone a natural assimilation into the more complex whole, thus becoming cells or cooperative parts of cells. Some forms have not, or not yet, become assimilated into tissue, and so appear as separate symbionts. The intestinal bacteria are an excellent example. Based on this theory, an entertaining conjecture is that since the primordial, colonizing forms are plant life, animals don’t exist per se, so that humans are complex, mobile, talking vegetation.

Unfortunately, Micro-Cosmos lacks the insight microzymian principle might bring to it. It fails to recognize life prior to the cell, and therefore cannot consider what may be the primary orchestrative tools of the colonization process. It discusses DNA repair enzymes with no suggestion as to their origin.

This article also does not take into account the rapid functional changes of microforms in response to terrain imbalance, and is mystified by cancer:

“It is as if the uneasy alliances of the symbiotic partnerships that maintain the cells disintegrate. The symbionts fall out of line, once again asserting their independent tendencies. . . . The reasons, of course, are not all that clear, but cancer seems more an untimely regression than a disease.”  Here is what seems a struggle with the bonds of the Pasteurian decalogue. The symbionts falling out of line might easily have been expressed, “The microzymas change their function.” 

Confirmation of Bechamp

There have been many modern and contemporary confirmations of various aspects of Bechamp’s work. One of the earliest and most piquant was reported in an article in The Times, a London newspaper, on April 8, 1914. A French bacteriologist, Mme. Henri, had succeeded in transforming an anthrax bacillus into a coccus form having entirely different functional properties. It could easily have been explained by Professor Bechamp, who sat virtually unrecognized at the London Medical Congress in 1881, where plagiarist Pasteur appeared amidst outbursts of cheering as his country’s representative, and where, as reported in The Times, August 8, 1881, he categorically denied the pleomorphism of B. anthracis.

Pasteur also jumped to the conclusion that each kind of germ produces one specific fermentation, while Bechamp proved that a microorganism might vary its fermentation effect in conformity with the surrounding medium. Bechamp’s assertion that these microforms, under varying conditions, might even change their shape was proved conclusively by F. Loehnis and N.R. Smith of the U.S. Department of Agriculture in 1916 {Journal of Agricultural Research, July 31,1919, p. 675).

And, for evidence that the biological terrain is the determinant factor over the mere presence of a symptogenic microform, we may return to Kalokerinos and Dettman:  

It should come as no surprise to discover that almost every pathogen may be isolated from the majority of so-called “healthy” people: Candida is such an example, and here we quote from the Manual of Clinical Mycology (Conant, Smith, Baker & Calloway, 1971): “Since pathogenic strains of C. albicans can be isolated from (1) normal skin, (2) normal oral and vaginal mucous membranes and (3) stools of normal individuals, it is obvious that most infections have an endogenous source, and the determination of the source of the infection is as difficult as it is with Staphylococcus aureus infections.

This revelation also highlights a recent example of the false conclusions to which one is led by germ theory: The news in research on atherosclerosis is that scientists have isolated a chlamydia-type organism in the plaque, and have concluded that it is the cause of this symptom. The plan is to use antibiotics to combat this “pathogen.” There is only one guarantee in this folly: at the very best they may achieve atherosclerosis without the chlamydia. At worst, they will exacerbate the mounting crisis in health caused by a half-century of antibiotic abuse.

R.R. Rife

images-42

Perhaps the most profound confirmation of pleomorphism was executed by another nearly obliterated genius, this time an American microscopist with the alliterative name of Royal Raymond Rife. His story was told in an impressive piece of work called “The Rife Report” by investigative reporter Barry Lynes. It has been published in book form as The Cancer Cure That Worked!, which is highly recommended from several standpoints-for its revelations about Rife’s research and technology, which would be astounding for these times, never mind for the late 1920s to mid-30s; for a wonderful background on many pioneering figures in biology; for anyone interested in a deeper understanding of where medicine has gone in the United States; and not least, for a wonderful Foreword by John W. Mattingly of Colorado State University, whose writing has always been an inspiration whenever encountered.

Rife’s extraordinary microscope (with 31,000 diameters resolution), reported on in great detail in the Feb. 1944 Journal of the Franklin Institute (Vol. 237, No. 2), was capable of detail and clarity surpassing the newly emerging electron microscopes. Its use of prismatically dispersed natural light frequencies, rather than electron beams and acid stains, allowed clear views of living subjects. Weighing 200 pounds, standing 2 feet high, and consisting of 5,682 (!) parts, the Rife Universal Microscope was an unsung wonder of the world, and the world has thus far been robbed of this absolutely elegant design.

In 1920 Rife began doing research in the electronic treatment of “disease,” specifically to find a way to destroy the tubercle bacillus by means of radio frequency (r.f.) radiation. Attempts to do so were trial and error because the organism’s resonant frequency was unknown. Lynes tells us that when the frequency was finally found and the bacteria killed, the subjects (poor guinea pigs!) died of toxicity. Rife reasoned that there was a viral form in the bacteria that survived the beam because it had a different frequency. But the virus was beyond the reach of his current microscope, which relied on chemical stains. Through an intuitive flash, he “conceived first the idea and then the method of staining the virus with light.’’’’ The idea was based on the principle of resonant frequency. Each microorganism has its own fundamental frequency of light, something Bechainp apparently took advantage of with his polarimeter. Rife arrived at the conclusion that light could be used, instead of fatal chemicals, to “stain” the subject. This was brilliant. Equally brilliant was its execution. A brief, partial description of the instrument, taken from the Journal’s review, is irresistible:

The entire optical system-lenses and prisms, as well as the illuminating units-are made of block-crystal quartz. The illuminating unit used for examining the filterable forms of disease organisms contains fourteen lenses and prisms, three of which are in the high-intensity incandescent lamp, four in the Risley prism, and seven in the achromatic condenser, which incidentally has an aperture of 1.40. Between the source of light and the specimen are subtended two circular, wedge-shaped, block-crystal quartz prisms for the purpose of polarizing the light passing through the specimen, polarization being the practical application of the theory that light waves vibrate in all planes perpendicular to the direction in which they are propagated. When light comes into contact with a polarizing prism, it is split into two beams, one of which is refracted to such an extent that it is reflected to the side of the prism, without, of course, passing through the prism, while the second ray, bent considerably less, is enabled to pass through the prism to illuminate the specimen. When the quartz prisms on the Universal Microscope, which may be rotated with vernier control through 360 degrees, are rotated in opposite directions, they serve to bend the transmitted beams at variable angles of incidence while, at the same time, since only a part of a band of color is visible at one time, a small portion of the spectrum is projected up into the axis of the microscope. It is possible to proceed this way from one end of the spectrum to the other-infra-red to ultra-violet. Now, when that portion of the spectrum is reached in which both the organism and the color band vibrate in exact accord with one another, a definite, characteristic wavelength is emitted by the organism. In the case of the filter­passing form of the Bacillus typhosus, for instance, a blue light is emitted, and the plane of polarization is deviated plus 4.8 degrees. … A monochromatic beam of light corresponding exactly to the frequency of the organism is then sent up through the specimen and the direct, transmitted light, enabling the observer to view the organism stained in its true chemical color and revealing its own structure in a field which is brilliant with light.

Recall that Bechamp said the chemist would identify microzymas by their function. Their evolved forms would also have a chemical function, or in this case, a signature. Thus, we evolved scientifically from analysis based on light polarizations to that based on the emission of light frequencies, which Rife referred to as the organism’s “true chemical refractive index.”

The Journal then explains that instead of light rays from the specimen passing through the objective and converging, they pass through a series of special prisms which keep the rays parallel:

It is this principle of parallel rays in the Universal Microscope, and the shortening of projection distance between the prisms, plus the fact that three matched pairs of ten-millimeter, seven-millimeter and four-millimeter objectives in short mounts are substituted for oculars, which make possible not only the unusually high magnification and resolution, but which serve to eliminate all distortion as well as all chromatic and spherical aberration….The coarse adjustment, a block thread screw with forty threads to the inch, slides in a one and one-half inch dovetail which gibs directly onto the pillar post. The weight of the quadruple nosepiece and the objective system is taken care of by the intermediate adjustment at the top of the body tube. The stage, in conjunction with a hydraulic lift, acts as a lever in operating the fine adjustment. A six-gauge screw having a hundred threads to the inch is worked through a gland into a hollow glycerine-filled post, the glycerine being displaced and replaced as the screw is turned, allowing a five to one ratio on the lead screw. This, accordingly, assures complete absence of drag and inertia. The fine adjustment being seven hundred times more sensitive than that of ordinary microscopes, the length of time required to focus ranges up to one hour and a half.

A major upshot of Rife’s work was his ability, through several pleomorphic stages, to transform a virus he found in cancer tissue into a fungus, plant the fungus in an asparagus- based medium, and produce a bacillus E. coli, the type of microform indigenous to the human intestine. This was repeated hundreds of times. By this accomplishment, Rife showed that the pleomorphic capacity of microforms goes beyond the bacterial level to the fungal level. Dr. Young has observed this cycle, and is suggesting that its progression to the last stage-mold-is critical. And he includes in this cycle the very important stages intermediate to microzymas and bacteria, the protein complexes usually referred to as viruses, and their immediate descendants, the cell-wall deficient forms detailed by Lida Mattman, Ph.D.

What’s more, Rife identified 10 families in the whole spectrum of microlife. Within each family, any form/member could become any other. Also, the fact that organisms have resonant frequencies allowed Rife to further develop his r.f. “beam ray,” which helped rid the body of cancer symptoms.

Apparently, Rife was not aware of Bechamp. Had he been (he was about 20 years old when Bechamp died on the other side of the Atlantic), a light of another frequency might have been thrown on his research,  What a marvelous and beneficial revelations might have arisen with Rife’s technology guided by Bechamp’s vision?  However, even though saddled i the beginning with a germ-theory mindset, he managed to rise above its worst effects.  Demonstrating an instinctive understanding of the disease process, Rife made the following statement: ” We do not wish at this time to claim that we have cured cancer, or any disease, for that matter.  But we can say that  these waves, or this ray, as the frequencies might be called, have been shown to possess the power of devitalizing disease organisms, or ‘killing’ them when tuned to an exact wavelength, or frequency, for each different organism.”  And again: “In reality, it is not the bacteria themselves that produce the disease, but the chemical constituents of these microorganisms enacting upon the unbalanced cell metabolism of the human body that in actuality produce the disease.  We also believe if the metabolism .  . . is perfectly balance or poised, it is susceptible to no disease.”

While he was making the classic error (perhaps a semantic one) of referring to symptoms as the disease, he seemed aware that disease-associated microorganisms do not originally produce the condition which has supported their morbid evolution in the animal or human body.  This fine, but critical, distinction is missing in the views of all the researchers reported on in Lynes’ book.  Even as they stood opposed to the orthodoxy, they still pursed these morbidly evolved symptoms with the intent of curing the visible, or diagnosed “disease.”

When Rife first destroyed the tubercle bacillus, the guinea pigs died of toxic poisoning. Could that poison have been bacterial debris, including endotoxin, and the death a severe Herxheimer reaction? Rife went on to search for a virus he assumed was released when the bacteria died, but if he had understood what Bechamp explained and what I am emphasizing now, he would have known that the organism’s microzymas were thus set free in the medium. And we can now understand that there was no virus per se, but only variously complexed microzymas.

As a poignant insight into the passion of a man of brilliance whose revelations were denied to the world by avarice, Lynes presents a report given in 1958 by one of Rife’s co­workers, who had known him from the early days of his career:

“He finally got to a point where from years of isolation and clarification and purification of these filterable forms, he could produce cancer in the guinea pigs in two weeks. He tried it on rats, guinea pigs and rabbits, but he found finally that he could confine his efforts to guinea pigs and white rats, because every doggone one was his pet. And he performed on them . . . the most meticulous operations you ever want to see in all your born days. No doctor could ever come near to it.

“He had to wear a big powerful magnifying glass. He performed the most wonderful operations you ever saw. Completely eradicating every tentacle out from the intestines, and sewed the thing up and it got well and didn’t know anything about it at all. Did it not once but hundreds of times. This is a thing that again and again I wish was published. I wish with all my heart that all the detailed information that he developed could be published because the man deserves it.”

“He finally got these cultures on the slide. He could look through this thing and you could see them swimming around absolutely motile and active.”

Then he’d say, ‘Watch that.’ He’d go turn on the frequency lamps. When it got to a certain frequency, he’d release the whole doggone flood of power into the room. The doggone little things would die instantly.’

“He built the microscopes himself. He built the micro-manipulator himself. And the micro-dissector and a lot of other stuff.”

“I’ve seen Roy sit in that doggone seat without moving, watching the changes in the frequency, watching when the time would come when the virus in the slide would be destroyed. Twenty-four hours was nothing for him. Forty-eight hours. He had done it many times. Sat there without moving. He wouldn’t touch anything except a little water. His nerves were just like cold steel. He never moved. His hands never quivered.

“Of course he would train beforehand and go through a very careful workout afterward to build himself up again. But that is what I would call one of the most magnificent sights of human control and endurance I’d ever seen.

“I’ve seen the cancer virus. I have seen the polio virus. I’ve seen the TB virus. Here was a man showing people, showing doctors, these viruses of many different kinds of diseases, especially those three deadly ones-TB, polio and cancer.

“Time and time again since that time some of these medical men have made the proud discovery that they had isolated we will say one of the viruses of cancer, had isolated one of the viruses of polio. Why, that was one of the most ridiculous things in the world. Thirty-five years ago Roy Rife showed them these things.

“These machines demonstrate that you could cure cancer- all crazy notions of usurping the rights of the AMA notwithstanding. They definitely could take a leaf out of Roy Rife’s book and do an awful lot of good to this world for sickness and disease. As a consequence, we have lost millions of people that could have been healed by Rife’s machines.”

“I like Roy Rife. I’ll always remember Roy as my Ideal. He had a tremendous capacity for knowledge and a tremendous capacity for remembering what he had learned. He definitely was my Ideal. Outside of old Teddy Roosevelt, I don’t know of any man any smarter than him and I’ll bank him up against a hundred doctors because he did know his stuff with his scientific knowledge in so many lines. He had so many wrinkles that he could have cashed in and made millions out of it if he had wanted to and I do mean millions of dollars. Which would have benefited the human race, irrespective of this tremendous thing that he built which we call the Rife ray machine.”

“In my estimation Roy was one of the most gentle, genteel, self-effacing, moral men I ever met. Not once in all the years I was going over there to the lab, and that was approximately 30 years, did I ever hear him say one word out of place.”

“All the doctors used to beat a path to Rife’s lab door and that was a beautiful lab at one time. It was beautifully arranged inside. The equipment was just exactly right; his study was just wonderful. It was a place of relics and the atmosphere could not be duplicated anywhere.”

(It is noteworthy that even though Rife entered the realm of vivisection, he at least showed the compassion to fix the damaged animals.)

More Cosmic Tones

For some time there have been “Rife instruments” on the market, using his frequencies in an electrode-pad configuration, and sold for research purposes. But that r.f. beam ray, that was the “magic,” technologically speaking, at least. And now an instrument has appeared claiming to be a re-creation of the original (see “Revival and Caution” below). Rife would probably have been the first to question whether the beam deals with the underlying disease condition. In this respect, I would like to suggest a consideration of the beam in terms of both the microzyma and the yogic principle of the chakras.

images-43

In yoga, the chakras (“wheels” or vortices of energy) are said to be the “organs” of the subtle body (the energy blueprint of the being). They are tuned to light frequencies corresponding to the colors of the rainbow. One’s personality, physical and physiological qualities, and even the health of the individual are said to arise from their infinitely complex configurations and their interactions with other fields. They are also spiral vortices through which the meridians of acupuncture flow. By way of the neurolymphatic reflexes and neurovascular points of the body, these flowing energies are intimate with the systems, organs, cells and chemistry of the physiology.

In terms of what was suggested earlier about the cosmic microzyma, consider what Christopher Hills, yogi and physicist, has written:

“… (It is) very likely that the chromosome, when exerting its biochemical effects in replication is NOT an indivisible unit with all its many constituents, in a precise, unchanging hereditary chemical pattern existing from one generation to the next. It is, of course, subject to evolutionary CHANGE. Yet in their function, these chromosomes have to be capable of precise replication, so they must spontaneously aggregate into patterns of LIFE (consciousness of form), which is characterized by the chemical environment in the nucleus of the cell. Any change in this immediate environment, such as a change in the specific frequency of a sharply selected energy, of radiation, of light, of electromagnetic waves or of sound, may alter not only the structural relationship of the molecules in the cell nucleus, but also their biochemical and genetic activity.”

(Taken from pp. 813-814 of Nuclear Evolution, a work on the physics of Consciousness published in 1977, almost one century after Bechamp created the name “microzyma.”)

“Consequently, what if the Rife beam, in addition to its resonant effect on microforms, was influencing the frequency balance of the chakras or the balance and freedom of flow in the meridians, perhaps doing what might be called R.F. Acupuncture, and perhaps ultimately “tuning” the microzymas? This might constitute a sufficient rebalancing of the being, or an altering of its vibrational condition, to be considered curative; and it might be maintained if the individual were subsequently to nurture their psychobiological terrain, which includes “the chemical environment in the nucleus of the cell.”

Leading the Horse to Water

What more could the scientific world have been waiting for than what Rife showed it? Significantly, he was not working in a vacuum but had the attention and support of respected biomedical scientists and doctors, including Dr. Edward C. Rosenow of the Mayo Clinic; Dr. Arthur I. Kendall, Director of Medical Research at Northwestern U. Medical School; and Dr. Milbank Johnson, member of the board of directors at Pasadena Hospital in California. As Lynes informs us, newspapers reported on Rife’s work, including significant clinical success. And as noted, no less a prestigious organization than the Franklin Institute did a detailed report on him. But, not only did the medical establishment (AMA) turn its back on Rife and his safe, effective means of eradicating cancer symptoms, but it systematically conspired to destroy him-which it did not once, but twice. Thus, Bechamp and then his unwitting supporter, Rife, geniuses of the caliber of Copernicus, Galileo and Lavoisier, were rubbed into obscurity. (While on this note, we might remember another genius pleomorphist, Wilhelm Reich, who died miserably in an American prison for attempting to bring truth to light.)

It didn’t take much to see that if Pasteur’s noxious poisons could garner even a semblance of success, the monetary potential would be stupendous. Thus, his greatest claim to fame ought to have been the inauguration of the “calamitous prostitution of science and medicine to commercialism” (Hume). Research facilities modeled after the one opened in 1888 in Paris, and used for brutal experimentation on living animals, as well as the production and sale of vaccine drawn from sickened bodies, came into existence all over the world. Bechamp’s brilliant expositions took second place to the dawning of a “new” era. It was the era of stone-hearted torture of fellow creatures and cruelty to our own species. It was the era in which bacterial disease symptoms were supplanted over time with a second wave of modern chronic fungal “infection.” Surfing this wave of degenerative mycotic infestation-officially unacknowledged as such-partially comprising heart disease, cancer, diabetes, so-called autoimmune disease and AIDSyndrome, were the profiteers, supported by arrogant, single-minded adherence to a scientifically and philosophically flawed, superficially plausible, and financially exploitable model of life and health.

Lynes tells us that Rife found himself in the path of Morris Fishbein, the Hitlerian ruler who headed the AMA from the mid-1920s until 1949, when he was forced from his position by a revolt among doctors. In Chicago, Fishbein had gotten wind of a clinic in San Diego using Rife’s beam-ray method of eliminating cancer symptoms. When refused a buy-in, he used his influence to bring the manufacturing company down in court for operating without a license. This blow to medicine in the late 1930s was a major step in suppressing the knowledge of pleomorphism, the mind-boggling Rife Universal Microscope, and the amazing radio frequency beam instrument used in the clinical setting.

In the second wave of suppression, the establishment (FDA) “Elliot-Nessed” a factory established in the 1950s by Rife and associate John Crane to manufacture the beam ray instrument. Everything was destroyed, records confiscated, and every practitioner possessing a unit was pursued and forced to surrender it as illegal.

Many other courageous individuals have been a part of the process of bringing the hidden truth about microorganisms and their symptogenic properties to light. One of the most significant is Dr. Virginia Livingston-Wheeler. Though she is discussed in the main text, she deserves another mention as a key figure who also faced suppression-the stress of being made invisible-by the sciomeds (power structure of scientific medicine). She published a book in 1983, The Conquest of Cancer, and, according to Lynes, wrote many articles and made presentations to science societies, including the New York Academy of Science, and international conferences. Lynes reports that she once returned from a presentation at an international symposium in Rome to find that her research funds with a major hospital had been canceled and the laboratory closed. During the four or five decades following the first establishment backlash at Rife, several other scientists, including Dr. Eleanor Alexander-Jackson, Dr. Irene Cory Diller, and Lida Mattman, Ph.D. (cell-wall deficient forms), stood in the face of intimidation to continue the valiant, yet feeble, tradition of unbiased biomedical science.

Revival and Caution

There is now afoot, as recently shown on the television show “Strange Universe” (March, 1997), a movement to revive the Rife beam-tube technology. Equipment was shown, as were moving pictures of the lysis of several unidentified microorganisms implied to be culprits in disease. Testimonies were given by a few people saying that they, or people they knew, have been helped by this beam ray. While this is an interesting and promising development, a note of caution is very much in order, so that folks do not end up like Rife’s guinea pigs, being put to death by a violent Herxheimer reaction. I believe the approach I recommended by is safer-more holistic and harmonically based in that we make the environment dissatisfactory to these symptoms of disease, so that instead of exploding on the spot and spewing poisons, they simply “pack their bags and leave.” That is, they will, of themselves, devolve into stages of the pleomorphic cycle consistent with the frequencies natural to a harmonious terrain; or will become so devitalized that the immune system can easily trash them.

It is hoped that this overview has given a provocative taste of what lies obscured in the history of biology. The reader is encouraged to explore the Hume and Lynes books especially, as well as that of the beacon of 19th-century bioscience, Antoine Bechamp: The Blood and Its Third Anatomical Element. 

A Note of Emphasis:

In this writer’s opinion, it is a poverty of compassion, the utmost arrogance, faultiness of perspective, and an error of science to inflict self-generated human miseries on innocent animal species in research laboratory experiments. Each year some 100 million animals are killed. Though many such experiments are used as references in this book, this is not a sanction. It is done to show the kind of results being ignored by “authorities” who believe in these methods, to accommodate professionals who live by them, to appease reductionist minds, and to suggest that enough is enough.  Human development and quality of life are unlikely to improve in any way by this torture of fellow creatures, unless such change occurs in the heart to make such practice unthinkable. The benefit to science and society is highly speculative and frequently negative. Let the experiments be done on human volunteers, whose physiology at least lends some logic to the process. Thalidomide was animal tested. Aspirin will kill a cat. Sheep can eat arsenic.

The habitual basis for vivisection is not founded in true science, but in profound alienation from nature and detachment from the nature of being. It continues out of species prejudice and an egocentric machismo that feeds on conquering nature via destructive analysis. It continues out of a merry-go-round intent to keep laboratories busy, researchers working, and to keep the research supply industry rolling in money. And it continues out of the habitual ignore-ance of the principles of wellness, which have long been in place in many forms. The fault for our rampant “diseases” may be ascribed to such ignorance and not laid at the feet of helpless animals, who play no part except to suffer for us and to die by the hundreds of millions. This is an insult to the Creation, not to mention an ecological disaster from the disposal of bodies. And to make matters worse, much of the research is based upon biased and erroneous science.

But the bottom line is, though we have the power over these creatures to inflict our cruelty on them, to do so may have dire consequences, given a Universe that operates on balance. Individuals of compassion and conscience may wish to consider opposing, through words and actions, this Frankensteinian madness. 

General References 

[1]  Bechamp, Pierre Jacques Antoine. The Blood and Its Third Anatomical Element .(Montague R. Leverson, translator). London: John Ouseley Limited, 1912.

[2]  Bird, Christopher. Gaston Naessens. Tiburon, Cal.: H.J. Kramer, Inc., 1991.

[3]  Bird, Christopher. To Be or Not to Be?. A paper presented in an address to L’Orthobiologie Somatidienne Symposium 1991, Sherbrooke, Quebec, hosted by Gaston Naessens.

[4]  Hills, Christopher. Nuclear Evolution. Boulder Creek, Cal.: University of the Trees Press, 1977 (out of print).

[5]  Hume, E. Douglas. Bechamp or Pasteur? Ashingdon, Rochford, Essex, England: The C.W. Daniel Co. Ltd., 1923.

[6]  Kalokerinos, A. and Dettman, G. Second Thoughts About Disease/ A Controversy and Bechamp Revisited. Warburton, Victoria, Australia: Biological Research Institute [booklet published from an article in Journal of the International Academy of Preventive Medicine-, July 1977; 4(1)].

[7]  Lynes, Barry. The Cancer Cure That Worked! Fifty Years of Suppression. Queensville, Ontario, Canada: Marcus Books, 1987.

[8]  Margulis, Lynn and Sagan, Dorion. Micro-Cosmos. New York: Summit Books, 1986.

[9]  R.O. Young, Sick and Tired, Reclaim Your Inner Terrain.  Woodland Publishing, Orem, Utah, 1999.

[10]  R.O. Young, S.R. Young, The pH Miracle, Hachette Publishing, New York, New York, 2010.

 

 

Harvard Trained Immunologist Demolishes California Legislation That Terminates Vaccine Exemptions

78764-babyandvaccines

The following open letter by a PhD Immunologist completely demolishes the current California legislative initiative to remove all vaccine exemptions. That such a draconian and cynical state statute is under consideration in the ‘Golden State’ is as shocking as it is predictable.  After all, it was mysteriously written and submitted shortly after the manufactured-in-Disneyland measles ‘outbreak’.

The indisputable science that is employed by Tetyana Obukhanych, PhD ought to be read by every CA legislator who is entertaining an affirmative vote for SB277.  Dr. Obukhanych skillfully deconstructs the many false and fabricated arguments that are advanced by Big Pharma and the U.S Federal Government as they attempt to implement a nationwide Super-Vaccination agenda.

When the California Senate refuses to consider authoritative scientific evidence which categorically proves the dangerous vaccine side effects on the schoolchildren, something is very wrong. Such conduct by the Senate constitutes criminal action that endangers the lives and welfare of children. Their official behavior must be acknowledged for what it is — CRIMINAL — and prosecuted to the fullest extent of the law.

An Open Letter to Legislators Currently Considering Vaccine Legislation from Tetyana Obukhanych, PhD in Immunology

Re:  VACCINE LEGISLATION

Dear Legislator:

My name is Tetyana Obukhanych. I hold a PhD in Immunology.  I am writing this letter in the hope that it will correct several common misperceptions about vaccines in order to help you formulate a fair and balanced understanding that is supported by accepted vaccine theory and new scientific findings.

Do unvaccinated children pose a higher threat to the public than the vaccinated?

It is often stated that those who choose not to vaccinate their children for reasons of conscience endanger the rest of the public, and this is the rationale behind most of the legislation to end vaccine exemptions currently being considered by federal and state legislators country-wide. You should be aware that the nature of protection afforded by many modern vaccines – and that includes most of the vaccines recommended by the CDC for children – is not consistent with such a statement. I have outlined below the recommended vaccines that cannot prevent transmission of disease either because they are not designed to prevent the transmission of infection (rather, they are intended to prevent disease symptoms), or because they are for non-communicable diseases. People who have not received the vaccines mentioned below pose no higher threat to the general public than those who have, implying that discrimination against non-immunized children in a public school setting may not be warranted.

  1. IPV (inactivated poliovirus vaccine) cannot prevent transmission of poliovirus (see appendix for the scientific study, Item #1). Wild poliovirus has been non-existent in the USA for at least two decades. Even if wild poliovirus were to be re-imported by travel, vaccinating for polio with IPV cannot affect the safety of public spaces.  Please note that wild poliovirus eradication is attributed to the use of a different vaccine, OPV or oral poliovirus vaccine. Despite being capable of preventing wild poliovirus transmission, use of OPV was phased out long ago in the USA and replaced with IPV due to safety concerns.
  1. Tetanus is not a contagious disease, but rather acquired from deep-puncture wounds contaminated with C. tetani spores. Vaccinating for tetanus (via the DTaP combination vaccine) cannot alter the safety of public spaces; it is intended to render personal protection only.
  1. While intended to prevent the disease-causing effects of the diphtheria toxin, the diphtheria toxoid vaccine (also contained in the DTaP vaccine) is not designed to prevent colonization and transmission of C. diphtheriae. Vaccinating for diphtheria cannot alter the safety of public spaces; it is likewise intended for personal protection only.
  1. The acellular pertussis (aP) vaccine (the final element of the DTaP combined vaccine), now in use in the USA, replaced the whole cell pertussis vaccine in the late 1990s, which was followed by an unprecedented resurgence of whooping cough. An experiment with deliberate pertussis infection in primates revealed that the aP vaccine is not capable of preventing colonization and transmission of B. pertussis (see appendix for the scientific study, Item #2). The FDA has issued a warning regarding this crucial finding.[1]
  • Furthermore, the 2013 meeting of the Board of Scientific Counselors at the CDC revealed additional alarming data that pertussis variants (PRN-negative strains) currently circulating in the USA acquired a selective advantage to infect those who are up-to-date for their DTaP boosters (see appendix for the CDC document, Item #3), meaning that people who are up-to-date are more likely to be infected, and thus contagious, than people who are not vaccinated.
  1. Among numerous types of H. influenzae, the Hib vaccine covers only type b. Despite its sole intention to reduce symptomatic and asymptomatic (disease-less) Hib carriage, the introduction of the Hib vaccine has inadvertently shifted strain dominance towards other types of H. influenzae (types a through f).These types have been causing invasive disease of high severity and increasing incidence in adults in the era of Hib vaccination of children (see appendix for the scientific study, Item #4).  The general population is more vulnerable to the invasive disease now than it was prior to the start of the Hib vaccination campaign.  Discriminating against children who are not vaccinated for Hib does not make any scientific sense in the era of non-type b H. influenzae disease.
  1. Hepatitis B is a blood-borne virus. It does not spread in a community setting, especially among children who are unlikely to engage in high-risk behaviors, such as needle sharing or sex. Vaccinating children for hepatitis B cannot significantly alter the safety of public spaces. Further, school admission is not prohibited for children who are chronic hepatitis B carriers. To prohibit school admission for those who are simply unvaccinated – and do not even carry hepatitis B – would constitute unreasonable and illogical discrimination.

In summary, a person who is not vaccinated with IPV, DTaP, HepB, and Hib vaccines due to reasons of conscience poses no extra danger to the public than a person who is.  No discrimination is warranted.

How often do serious vaccine adverse events happen?

It is often stated that vaccination rarely leads to serious adverse events. Unfortunately, this statement is not supported by science. A recent study done in Ontario, Canada, established that vaccination actually leads to an emergency room visit for 1 in 168 children following their 12-month vaccination appointment and for 1 in 730 children following their 18-month vaccination appointment (see appendix for a scientific study, Item #5).

When the risk of an adverse event requiring an ER visit after well-baby vaccinations is demonstrably so high, vaccination must remain a choice for parents, who may understandably be unwilling to assume this immediate risk in order to protect their children from diseases that are generally considered mild or that their children may never be exposed to.

Can discrimination against families who oppose vaccines for reasons of conscience prevent future disease outbreaks of communicable viral diseases, such as measles?

Measles research scientists have for a long time been aware of the “measles paradox.” I quote from the article by Poland & Jacobson (1994) “Failure to Reach the Goal of Measles Elimination: Apparent Paradox of Measles Infections in Immunized Persons.” Arch Intern Med 154:1815-1820:

“The apparent paradox is that as measles immunization rates rise to high levels in a population, measles becomes a disease of immunized persons.”[2]

Further research determined that behind the “measles paradox” is a fraction of the population called LOW VACCINE RESPONDERS. Low-responders are those who respond poorly to the first dose of the measles vaccine. These individuals then mount a weak immune response to subsequent RE-vaccination and quickly return to the pool of “susceptibles’’ within 2-5 years, despite being fully vaccinated.[3]

Re-vaccination cannot correct low-responsiveness: it appears to be an immuno-genetic trait.[4]  The proportion of low-responders among children was estimated to be 4.7% in the USA.[5]

Studies of measles outbreaks in Quebec, Canada, and China attest that outbreaks of measles still happen, even when vaccination compliance is in the highest bracket (95-97% or even 99%, see appendix for scientific studies, Items #6&7). This is because even in high vaccine responders, vaccine-induced antibodies wane over time.  Vaccine immunity does not equal life-long immunity acquired after natural exposure.

It has been documented that vaccinated persons who develop breakthrough measles are contagious. In fact, two major measles outbreaks in 2011 (in Quebec, Canada, and in New York, NY) were re-imported by previously vaccinated individuals.[6] – [7]

Taken together, these data make it apparent that elimination of vaccine exemptions, currently only utilized by a small percentage of families anyway, will neither solve the problem of disease resurgence nor prevent re-importation and outbreaks of previously eliminated diseases. 

Is discrimination against conscientious vaccine objectors the only practical solution?

The majority of measles cases in recent US outbreaks (including the recent Disneyland outbreak) are adults and very young babies, whereas in the pre-vaccination era, measles occurred mainly between the ages 1 and 15. Natural exposure to measles was followed by lifelong immunity from re-infection, whereas vaccine immunity wanes over time, leaving adults unprotected by their childhood shots. Measles is more dangerous for infants and for adults than for school-aged children.

Despite high chances of exposure in the pre-vaccination era, measles practically never happened in babies much younger than one year of age due to the robust maternal immunity transfer mechanism. The vulnerability of very young babies to measles today is the direct outcome of the prolonged mass vaccination campaign of the past, during which their mothers, themselves vaccinated in their childhood, were not able to experience measles naturally at a safe school age and establish the lifelong immunity that would also be transferred to their babies and protect them from measles for the first year of life.

Luckily, a therapeutic backup exists to mimic now-eroded maternal immunity. Infants as well as other vulnerable or immunocompromised individuals, are eligible to receive immunoglobulin, a potentially life-saving measure that supplies antibodies directed against the virus to prevent or ameliorate disease upon exposure (see appendix, Item #8).

In summary: 1) due to the properties of modern vaccines, non-vaccinated individuals pose no greater risk of transmission of polio, diphtheria, pertussis, and numerous non-type b H. influenzae strains than vaccinated individuals do, non-vaccinated individuals pose virtually no danger of transmission of hepatitis B in a school setting, and tetanus is not transmissible at all; 2) there is a significantly elevated risk of emergency room visits after childhood vaccination appointments attesting that vaccination is  not risk-free; 3) outbreaks of measles cannot be entirely prevented even if we had nearly perfect vaccination compliance; and 4) an effective method of preventing measles and other viral diseases in vaccine-ineligible infants and the immunocompromised, immunoglobulin, is available for those who may be exposed to these diseases. 

Taken together, these four facts make it clear that discrimination in a public school setting against children who are not vaccinated for reasons of conscience is completely unwarranted as the vaccine status of conscientious objectors poses no undue public health risk. 

Sincerely Yours,

Tetyana Obukhanych, PhD

Tetyana Obukhanych, PhD, is the author of the book Vaccine Illusion.  She has studied immunology in some of the world’s most prestigious medical institutions. She earned her PhD in Immunology at the Rockefeller University in New York and did postdoctoral training at Harvard Medical School, Boston, MA and Stanford University in California.

Dr. Obukhanych offers online classes for those who want to gain deeper understanding of how the immune system works and whether the immunologic benefits of vaccines are worth the risks:  Natural Immunity Fundamentals.

Appendix

Item #1. The Cuba IPV Study collaborative group. (2007) Randomized controlled trial of inactivated poliovirus vaccine in CubaN Engl J Med 356:1536-44

http://www.ncbi.nlm.nih.gov/pubmed/17429085

The table below from the Cuban IPV study documents that 91% of children receiving no IPV (control group B) were colonized with live attenuated poliovirus upon deliberate experimental inoculation.  Children who were vaccinated with IPV (groups A and C) were similarly colonized at the rate of 94-97%.  High counts of live virus were recovered from the stool of children in all groups.  These results make it clear that IPV cannot be relied upon for the control of polioviruses.

polio chart

Item #2. Warfel et al. (2014) Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.Proc Natl Acad Sci USA 111:787-92

http://www.ncbi.nlm.nih.gov/pubmed/24277828

“Baboons vaccinated with aP were protected from severe pertussis-associated symptoms but not from colonization, did not clear the infection faster than naïve [unvaccinated] animals, and readily transmitted B. pertussis to unvaccinated contacts. By comparison, previously infected [naturally-immune] animals were not colonized upon secondary infection.”

Item #3. Meeting of the Board of Scientific Counselors, Office of Infectious Diseases, Centers for Disease Control and Prevention, Tom Harkins Global Communication Center, Atlanta, Georgia, December 11-12, 2013

http://www.cdc.gov/maso/facm/pdfs/BSCOID/2013121112_BSCOID_Minutes.pdf

Resurgence of Pertussis (p.6)

“Findings indicated that 85% of the isolates [from six Enhanced Pertussis Surveillance Sites and from epidemics in Washington and Vermont in 2012] were PRN-deficient and vaccinated patients had significantly higher odds than unvaccinated patients of being infected with PRN-deficient strains.  Moreover, when patients with up-to-date DTaP vaccinations were compared to unvaccinated patients, the odds of being infected with PRN-deficient strains increased, suggesting that PRN-bacteria may have a selective advantage in infecting DTaP-vaccinated persons.”

Item #4. Rubach et al. (2011) Increasing incidence of invasive Haemophilus influenzaedisease in adults, Utah, USA. Emerg Infect Dis 17:1645-50

http://www.ncbi.nlm.nih.gov/pubmed/21888789

The chart below from Rubach et al. shows the number of invasive cases of H. influenzae(all types) in Utah in the decade of childhood vaccination for Hib.

Hib chart

Item #5. Wilson et al. (2011) Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysis. PLoS One 6:e27897

http://www.ncbi.nlm.nih.gov/pubmed/22174753

“Four to 12 days post 12 month vaccination, children had a 1.33 (1.29-1.38) increased relative incidence of the combined endpoint compared to the control period, or at least one event during the risk interval for every 168 children vaccinated.  Ten to 12 days post 18 month vaccination, the relative incidence was 1.25 (95%, 1.17-1.33) which represented at least one excess event for every 730 children vaccinated.  The primary reason for increased events was statistically significant elevations in emergency room visits following all vaccinations.”

Item #6. De Serres et al. (2013) Largest measles epidemic in North America in a decade–Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis 207:990-98

http://www.ncbi.nlm.nih.gov/pubmed/23264672

“The largest measles epidemic in North America in the last decade occurred in 2011 in Quebec, Canada.”

“A super-spreading event triggered by 1 importation resulted in sustained transmission and 678 cases.”

“The index case patient was a 30-39-year old adult, after returning to Canada from the Caribbean.  The index case patient received measles vaccine in childhood.”

“Provincial [Quebec] vaccine coverage surveys conducted in 2006, 2008, and 2010 consistently showed that by 24 months of age, approximately 96% of children had received 1 dose and approximately 85% had received 2 doses of measles vaccine, increasing to 97% and 90%, respectively, by 28 months of age.  With additional first and second doses administered between 28 and 59 months of age, population measles vaccine coverage is even higher by school entry.”

“Among adolescents, 22% [of measles cases] had received 2 vaccine doses.  Outbreak investigation showed this proportion to have been an underestimate; active case finding identified 130% more cases among 2-dose recipients.”

Item #7. Wang et al. (2014) Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination. PLoS One9:e89361

http://www.ncbi.nlm.nih.gov/pubmed/24586717

“The reported coverage of the measles-mumps-rubella (MMR) vaccine is greater than 99.0% in Zhejiang province.  However, the incidence of measles, mumps, and rubella remains high.”

Item #8. Immunoglobulin Handbook, Health Protection Agency

http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1242198450982

HUMAN NORMAL IMMUNOGLOBULIN (HNIG):

Indications

  1. To prevent or attenuate an attack in immuno-compromised contacts
  2. To prevent or attenuate an attack in pregnant women
  3. To prevent or attenuate an attack in infants under the age of 9 months

[1] http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376937.htm

[2] http://archinte.jamanetwork.com/article.aspx?articleid=619215

[3] Poland (1998) Am J Hum Genet 62:215-220

http://www.ncbi.nlm.nih.gov/pubmed/9463343

“ ‘poor responders,’ who were re-immunized and developed poor or low-level antibody responses only to lose detectable antibody and develop measles on exposure 2–5 years later.”

[4] ibid

“Our ongoing studies suggest that seronegativity after vaccination [for measles] clusters among related family members, that genetic polymorphisms within the HLA [genes] significantly influence antibody levels.”

[5] LeBaron et al. (2007) Arch Pediatr Adolesc Med 161:294-301

http://www.ncbi.nlm.nih.gov/pubmed/17339511

“Titers fell significantly over time [after second MMR] for the study population overall and, by the final collection, 4.7% of children were potentially susceptible.”

[6] De Serres et al. (2013) J Infect Dis 207:990-998

http://www.ncbi.nlm.nih.gov/pubmed/23264672

“The index case patient received measles vaccine in childhood.”

[7] Rosen et al. (2014) Clin Infect Dis 58:1205-1210

http://www.ncbi.nlm.nih.gov/pubmed/24585562

“The index patient had 2 doses of measles-containing vaccine.”

“As I Lay Dying..” LA Times Writer’s Last Words Will Make You Question Entire Breast Cancer Industry

 A former Los Angeles Times staff writer, Laurie Becklund, battled breast cancer since 1996. Earlier this year she knew her time was limited, and as she greeted her last few months, she wrote an opinion piece “As I Lay Dying” about her story. Becklund died Feb. 8 this year. This is what she wanted you to know about breast cancer.

Early detection does not cure cancer with mammograms DOES NOT SAVE LIVES!

Becklund: “I had more than 20 mammograms, and none of them caught my disease. In fact, we now have significant studies showing that routine mammogram screening, which may result in misdiagnoses, unnecessary treatment and radiation overexposure, can harm more people than it helps.”

To detect a cancer early in many cases means to catch it before it produces symptoms. That is a problem, because not every precancerous condition will actually become cancer or not the type of cancer that can affect a person’s life, but every case is treated as if it was the same type of cancer. Mammogram screening is responsible for about 25% of overdiagnosis in breast cancer, according to an article published in Oxford Journals. The overdiagnosis may harm patients and lead to “overuse of anticancer therapies” such as chemotherapy.

31% over diagnosed

Another article by The New England Journal of Medicine estimated that in 2008, 70,000 U.S. women were overdiagnosed with breast cancer, which is a shocking 31% of all breast cancer diagnoses.

list-428312_1280

The first time Becklund discovered a lump in her breast in 1996 during a self-exam, she was treated by a lumpectomy and radiation. She had the most “curable” type of breast cancer. Five years after the treatment her doctor told her she had minimal chance of it ever coming back.

Yet in 2009 she received a diagnosis of stage IV breast cancer that spread to her bones, liver, lungs and brain.

Metastatic breast cancer (MBC) is the only kind of breast cancer that kills

Metastatic cancer is “cancer that has spread from the place where it first started to another place in the body,” states Cancer.org. According to a non-profit patient advocacy group Metastatic Breast Cancer Network (MBCN) breast cancer itself does not kill, instead breast cancer patients die from cancer cells travelling to other vital organs.

Breast cancer most commonly spreads to bone, brain, liver and lung. And in Becklund’s case it spread to all four places. When she went to an MBCN conference other attendees were shocked that she was even alive. Almost everyone else had cancer spread to only one organ. When later a group of people she was in was asked to stand if they survived 2 years after diagnosis, most sat down. As far as she could see Becklund was the only one standing for 7 years of survival.

The medical establishment fails their patients

An estimated 40,000 MBC patients die annually. Another 250,000 are waiting for their death.

“I say ‘estimated because no one is required to report a metastatic diagnosis. Death certificates normally report symptoms such as “respiratory failure,” not the actual disease. We are literally uncounted,” Becklund wrote.

Lauire Becklund speaks to an audience. PHOTO: Stanford Medical X/Flickr

Lauire Becklund speaks to an audience. PHOTO: Stanford Medical X/Flickr

While the Surveillance, Epidemiology and End Results (SEER) Program is the main source for cancer statistics, it does not take into account metastatic breast cancer, according to MBCN. It is however estimated up to 30% of all cases are metastatic, and yet they are not counted. Moreover, only 2% of all breast cancer research has been estimated to go towards finding a solution for preventing or treating metastatic breast cancer, according to METAvivor, a non-profit MBC patients’ advocacy organization.

There is no one “cure”

“We are each, in effect, one-person clinical trials. Yet the knowledge generated from those trials will die with us because there is no comprehensive database of metastatic breast cancer patients…” Becklund wrote.

While there is a belief that if a person lives 5 years after the diagnosis they are a cancer survivor, for patients with MBC that means almost nothing. Though there is a treatment, MBC is incurable, according to Fred Hutchinson Cancer Research Center.

Early detection does not help MBC patients either. Another type of breast cancer that was once labeled “cured” by doctors, often comes back years later as stage IV metastatic. And one type of treatment does not work for all MBC patients.

Right now, while new therapies are just starting to emerge, there is still little hope for survival for MBC, and natural and holistic therapies that have shown promise are routinely ignored.

Susan G. Komen’s mission is not helping anyone

list-428312_1280 2“Promise that you’ll never wear a pink ribbon in my name or drop a dollar into a bucket that goes to breast cancer ‘awareness’ for ‘early detection for a cure,’ the mantra of fund-raising juggernaut Susan G. Komen, which has propagated a distorted message about breast cancer and how to ‘cure’ it,” Becklund wrote.

I would be surprised if I could find one literate person who is not aware that breast cancer exists and that it is life-threatening for many patients. We are fully aware of that fact. Now what?

Susan G. Komen’s income was $287,409,269 in 2014 and allegedly 79% went into its programs for education, research and support, yet besides being aware, the money spent for over 30 years ($2.6 billion worth) did little for the survival rates of the breast cancer that actually kills – MBC.

“Pink is pretty, but it does not disguise the fact that metastatic breast cancer kills,” reads METAvivor take-action page.

For thousands of women and men who are dying from MBC right now, that is a more believable and honest public-awareness campaign.  It is called The pH Miracle for Cancer – http://www.phoreveryoung.com

Alkalizing Fruit, Vegetables, Nuts, Seeds and Sprouts May Prevent or Reverse Depression!

Alkalizing Fruit, Vegetables, Nuts, Seeds and Sprouts May Prevent or Reverse Depression!
Dr. Robert Young

 M.Sc., D.Sc., Ph.D., N.D.

Naturopathic Physician at the pH Miracle Ti Sana Medical Spa, Arlate, Italy

Alkalizing Fruit, Vegetables, Nuts, Seeds and Sprouts May Prevent or Reverse Depression!

Eating a plant-based alkaline diet comprising of fruit, vegetables, sprouts, legumes, and healthy polyunsaturated oils is associated with preventing the onset of depression, according to research published in the open access journal BMC Medicine. A large study of 15,093 people suggests depression could be linked with nutrient deficits.

Following extensive research into diet and its effect on our physical health, researchers are now exploring the link between nutrition and mental health. This is the first time that several healthy dietary patterns and their association with the risk of depression have been analyzed together.

The researchers compared three diets; the Mediterranean diet, the Pro-vegetarian Dietary Pattern and Alternative Healthy Eating Index-2010. Participants used a scoring system to measure their adherence to the selected diet, i.e. the higher the dietary score indicated that the participant was eating a healthier diet.

Food items such as meat and sweets (sources of animal fats: saturated and trans fatty acids) were negatively scored, while nuts, fruit and vegetables (sources of omega-3 fatty acids, vitamins and minerals respectively) were positively scored.
Lead researcher, Almudena Sanchez-Villegas, University of Las Palmas de Gran Canaria, says “We wanted to understand what role nutrition plays in mental health, as we believe certain dietary patterns could protect our minds. These diets are all associated with physical health benefits and now we find that they could have a positive effect on our mental health.”

“The protective role is ascribed to their nutritional properties, where nuts, legumes, fruit and vegetables (sources of omega-3 fatty acids, vitamins and minerals) could reduce the risk of depression.”

The study included 15,093 participants free of depression at the beginning of the study. They are former students of the University of Navarra, Spain, registered professionals from some Spanish provinces and other university graduates. All are part of the SUN (Seguimiento Universidad de Navarra) Project, a cohort study started on 21st December 1999. The cohort has been used to identify dietary and lifestyle determinants of various conditions, including diabetes, obesity and depression.

Questionnaires to assess dietary intake were completed at the start of the project and again after 10 years. A total of 1,550 participants reported a clinical diagnosis of depression or had used antidepressant drugs after a median follow-up of 8.5 years.

The Alternative Healthy Eating Index-2010 was associated with the greatest reduction of risk of depression but most of the effect could be explained by its similarity with the Mediterranean Diet. Thus, common nutrients and food items such as omega-3 fatty acids, vegetables, fruits, legumes, nuts and moderate alcohol intake present in both patterns (Alternative Healthy Eating Index-2010 and Mediterranean diet) could be responsible for the observed reduced risk in depression associated with a good adherence to the Alternative Healthy Eating Index-2010.
Almudena Sanchez-Villegas says, “A threshold effect may exist. The noticeable difference occurs when participants start to follow a healthier diet. Even a moderate adherence to these healthy dietary patterns was associated with an important reduction in the risk of developing depression. However, we saw no extra benefit when participants showed high or very high adherence to the diets.
So, once the threshold is achieved, the reduced risk plateaus even if participants were stricter with their diets and eating more healthily. This dose-response pattern is compatible with the hypothesis that suboptimal intake of some nutrients (mainly located in low adherence levels) may represent a risk factor for future depression.”

A limitation of this study was that the results are based on self-reported dietary intake and a self-reported clinical diagnosis of depression. More research is needed to predict the role of nutrient intake for neurophysiological requirements and identify whether it is minerals and vitamins or proteins and carbohydrates that cause depression.

Read more: https://phoreveryoung.wordpress.com
Follow us: @drrobertyoung on twitter and The pH Miracle Fan Club on Facebook

The Cure for Cancer? That’s an easy question to answer! The Cure for Cancer is Found in its Prevention NOT in its Treatment! – Dr. Robert O. Young
Do you know what rotten apples, grapefruit or bananas look like? If you do then you know what cancer cells look like. Cancer cells are nothing more that healthy cells that are spoiling because of a compromised environment! Look at the picture below and you will see colorized cancerous body cells rotting in their toxic acidic environment.

What compromises the internal environment of a human body that causes body cells to begin spoiling and rotting? The answer is simple! The body’s build-up of acidic metabolic and dietary waste that has not been properly eliminated through the four channels of elimination – urination, defecation, respiration and perspiration!

Cancer is not a noun but an adjective that describes what is happening to body cells in an acidic environment due to an acidic lifestyle and diet. http://www.phoreveryoung.com

To learn more about Dr. Robert O. Young go to: https://www.linkedin.com/in/drrobertoyoung
To read more of Dr. Young’s articles go to: http://www.phoreveryoung.wordpress.com
To join Dr. Young on Twitter go to: @drrobertyoung
To watch more videos on YouTube go to: https://www.youtube.com/user/pHMiracleCenter
Join Dr. Young on Facebook at: The PH Miracle Medical Association or The pH Miracle
To purchase Dr. Young’s books or nutritional productts go to: http://www.phoreveryoung.com or http://www.phmiracle.com

%d bloggers like this: